2024

• Ratwatte, S., Stewart, S., Strange, G., Playford, D., Celermajer, D. (2024). Association of Pulmonary Artery Pressures With Mortality in Adults With Reduced Left Ventricular Ejection Fraction. JACC: Heart Failure, 12(5), 936-945. [More Information]
• Shafran, I., Skoro-Sajer, N., Probst, V., Panzenböck, A., Sadushi-Kolici, R., Gerges, C., Wolzt, M., Segel, M., Celermajer, D., Lang, I. (2024). Asymmetric Dimethylarginine and NT-proBNP Levels Provide Synergistic Information in Pulmonary Arterial Hypertension. JACC: Heart Failure, 12(6), 1089-1097. [More Information]
• Verrall, C., Tran, D., Kasparian, N., Williams, T., Oxenham, V., Ayer, J., Celermajer, D., Cordina, R. (2024). Cognitive Functioning and Psychosocial Outcomes in Adults with Complex Congenital Heart Disease: A Cross-sectional Pilot Study. Pediatric Cardiology. [More Information]
• Webster, S., Pittaway, E., Gillies-palmer, Z., Schlosberg, D., Matous, P., Longman, J., Howard, A., Bailie, J., Viney, G., Verlie, B., Celermajer, D., Naderpajouh, N., Rawsthorne, M., Iveson, K., Troy, J., et al (2024). Empowering Communities, Harnessing Local Knowledges: Self-Organising Systems for Disaster Risk Reduction.
• Providencia, R., Aali, G., Zhu, F., Katairo, T., Ahmad, M., Bray, J., Pelone, F., Khanji, M., Marijon, E., Cassandra, M., Celermajer, D., et al (2024). Handheld echocardiography for the screening and diagnosis of rheumatic heart disease: a systematic review to inform WHO guidelines. The Lancet Global Health, 12(6), e983-e994. [More Information]
• Kearney, K., Keogh, A., Kotlyar, E., Lavender, M., McWilliams, T., Williams, T., Whitford, H., Weintraub, R., Wrobel, J., Ellender, C., Lau, E., Celermajer, D., Cordina, R., et al (2024). Impact of Left Heart Disease Risk Factors on Outcomes in Pulmonary Arterial Hypertension Therapy. Chest. [More Information]
• Moonen, A., Cao, J., Celermajer, D., Ng, M. (2024). Mitral Regurgitation “Proportionality” in Functional Mitral Regurgitation and Outcomes After Mitral Valve Transcatheter Edge-to-Edge Repair: A Systematic Review and Meta-Analysis. Structural Heart, , 100284. [More Information]
• Providencia, R., Marijon, E., Cassandra, M., Celermajer, D., Shokraneh, F., Aali, G., Zhu, F., Leas, B., Orrell, R., Ahmad, M., et al (2024). Penicillin Allergy Testing and Delabeling for Patients Who Are Prescribed Penicillin: A Systematic Review for a World Health Organization Guideline. Clinical Reviews in Allergy and Immunology, 66(2), 223-240. [More Information]
• Aldweib, N., Alitibi, A., Opotowsky, A., Shah, S., Magalski, A., Cramer, J., Kauling, R., Dellborg, M., Krieger, E., Yeung, E., Celermajer, D., Baker, D., et al (2024). Prognostic Significance of Hemodynamics in Patients With Transposition of the Great Arteries and Systemic Right Ventricle. Circulation. Heart Failure, , e011882. [More Information]
• Chen, A., Codde, J., Stewart, S., Mocumbi, A., Ojji, D., Waite, L., Chan, Y., Beilby, J., Celermajer, D., Nkeh-Chungag, B., et al (2024). Projected burden and distribution of elevated blood pressure levels and its consequence among adolescents in sub-Saharan Africa. Journal of Global Health, 14, 04136. [More Information]
• Marshall, K., D'udekem, Y., Winlaw, D., Zannino, D., Celermajer, D., Justo, R., Iyengar, A., Cordina, R., Sholler, G., Woolfenden, S., et al (2024). Quality of Life and Well-Being in Adults With Fontan Physiology: Findings From the Australian and New Zealand Fontan Registry Quality of Life Study. Journal of the American Heart Association, 13(15), e033818. [More Information]
• Seitler, S., Arularooran, S., Shokraneh, F., Cassandra, M., Marijon, E., Celermajer, D., Khanji, M., Providencia, R., Ahmad, M., Ahuja, S., et al (2024). Routine Antenatal Echocardiography in High-Prevalence Areas of Rheumatic Heart Disease: A WHO-Guideline Systematic Review. Global Heart, 19(1), 39. [More Information]
• Webster, S., Pittaway, E., Gillies-palmer, Z., Schlosberg, D., Longman, J., Howard, A., Rawsthorne, M., Viney, G., Verlie, B., Celermajer, D., Bailie, J., Matous, P., Naderpajouh, N., Troy, J., et al (2024). Stories are the Toolkit: Community-led Disaster Response, Recovery and Adaptation.
• Paratz, E., Playford, D., Nadel, J., Humphries, J., Rowe, S., Fahy, L., Gerche, A., Prior, D., Celermajer, D., Strange, G. (2024). The aortic paradox: a nationwide analysis of 523 994 individual echocardiograms exploring fatal aortic dissection. European Heart Journal - Cardiovascular Imaging, 25(10), 1423-1431. [More Information]
• Koemel, N., Laouali, N., Senior, A., Celermajer, D., Grech, A., Solon-Biet, S., Simpson, S., Raubenheimer, D., Gill, T., Skilton, M. (2024). The Relationship between Dietary Macronutrient Composition and Telomere Length Among US Adults. Advanced Biology, 8(4). [More Information]
• Baker, D., O'Donnell, C., Cordina, R., Uthayakumaran, G., Polwart, N., Lee, M., Wilson, W., Ayer, J., Tanous, D., d'Udekem, Y., Celermajer, D. (2024). Transcatheter occlusion of venovenous collaterals in the total cavopulmonary Fontan circulation. Cardiology in the Young. [More Information]
• Bate, K., Genetzakis, E., Vescovi, J., Gray, M., Celermajer, D., McGuire, H., Grieve, S., Vernon, S., Cartland, S., Yang, J., Kavurma, M., Figtree, G. (2024). Vascular Cytokines and Atherosclerosis: Differential Serum Levels of TRAIL, IL-18, and OPG in Obstructive Coronary Artery Disease. Biomolecules, 14, 1119. [More Information]
• Marshall, K., Cordina, R., Sholler, G., Woolfenden, S., Kasparian, N., d'Udekem, Y., S.Winlaw, D., Zannino, D., Celermajer, D., Justo, R., et al (2024). Wellbeing in Children and Adolescents with Fontan Physiology. The Journal of Pediatrics, 273, 114156. [More Information]

2023

• Karimi Galougahi, K., Zhang, Y., Kienzle, V., Liu, C., Quek, L., Patel, S., Lau, E., Cordina, R., Figtree, G., Celermajer, D. (2023). β3 adrenergic agonism: A novel pathway which improves right ventricular-pulmonary arterial hemodynamics in pulmonary arterial hypertension. Physiological Reports, 11(1). [More Information]
• Kwok, C., Poon, Y., Chook, P., Guo, D., Lin, C., Yin, Y., Celermajer, D., Woo, K. (2023). A Potential Strategy for Atherosclerosis Prevention in Modernizing China — Hyperhomocysteinemia, MTHFR C677T Polymorphism and Air Pollution (PM2.5) on Atherogenesis in Chinese Adults. Journal of Nutrition, Health and Aging, 27(2), 134-141. [More Information]
• Moonen, A., Ng, M., Playford, D., Strange, G., Scalia, G., Celermajer, D. (2023). Atrial functional mitral regurgitation: Prevalence, characteristics and outcomes from the National Echo Database of Australia. Open Heart, 10(1). [More Information]
• Celermajer, D., Baker, D., Cordina, R., Gatzoulis, M., Broberg, C. (2023). Common diagnostic errors in adults with congenital heart disease. European Heart Journal, 44(34), 3217-3227. [More Information]
• Verrall, C., Tran, D., Yang, J., Lubans, D., Winlaw, D., Ayer, J., Celermajer, D., Cordina, R. (2023). Exercise as therapy for neurodevelopmental and cognitive dysfunction in people with a Fontan circulation: A narrative review. Frontiers in Pediatrics, 11. [More Information]
• Toro, C., Felmingham, B., Jhadav, M., Celermajer, D., La Gerche, A., O’Sullivan, J., Kumar, S., Mateos, M., Fulbright, J., Govender, D., Ayer, J., et al (2023). Lessons learnt in the first year of an Australian pediatric cardio oncology clinic. Cardio-Oncology, 9(1). [More Information]
• Koemel, N., Senior, A., Celermajer, D., Grech, A., Gill, T., Simpson, S., Raubenheimer, D., Skilton, M. (2023). Multi-Nutrient Analysis of Dietary Macronutrients with All-Cause, Cardiovascular, and Cancer Mortality: Data from NHANES 1999–2014. Nutrients, 15(2). [More Information]
• Lloyd, L., Nasir, J., Nicholson, C., Strange, G., Celermajer, D. (2023). Obstacles in establishing a national disease registry in Australia: lessons from the development of the CHAANZ Congenital Heart Disease Registry. Australian Health Review, 47(4), 410-417. [More Information]
• Offen, S., Puranik, R., Baker, D., Cordina, R., Chard, R., Celermajer, D. (2023). Prevalence and determinants of tricuspid regurgitation after repair of tetralogy of Fallot. International Journal of Cardiology, 372, 55-59. [More Information]
• Offen, S., Strange, G., Playford, D., Celermajer, D., Stewart, S. (2023). Prevalence and prognostic impact of tricuspid regurgitation in patients with cardiac implantable electronic devices: From the national echocardiography database of Australia. International Journal of Cardiology, 370, 338-344. [More Information]
• Ratwatte, S., Playford, D., Stewart, S., Strange, G., Celermajer, D. (2023). Prevalence of pulmonary hypertension in aortic regurgitation and its influence on outcomes. Heart, 109(17), 1310-1318. [More Information]
• Ratwatte, S., Stewart, S., Strange, G., Playford, D., Celermajer, D. (2023). Prevalence of pulmonary hypertension in aortic stenosis and its influence on outcomes. Heart, 109(17), 1319-1326. [More Information]
• Ratwatte, S., Strange, G., Playford, D., Stewart, S., Celermajer, D. (2023). Prevalence of pulmonary hypertension in mitral regurgitation and its influence on outcomes. Open Heart, 10(1). [More Information]
• James, N., Milijasevic, Z., Ujhazy, A., Huber, D., Rotne, R., Edwards, G., Jermyn, K., Celermajer, D. (2023). Safety evaluation of the Guardian device on the common carotid artery in sheep. Heliyon, 9(4). [More Information]
• Gallagher, R., Chow, C., Parker, H., Neubeck, L., Celermajer, D., Redfern, J., Tofler, G., Buckley, T., Schumacher, T., Hyun, K., Boroumand, F., Figtree, G. (2023). The effect of a game-based mobile app 'MyHeartMate' to promote lifestyle change in coronary disease patients: a randomized controlled trial. European Heart Journal - Digital Health, 4(1), 33-42. [More Information]
• Snir, A., Ng, M., Strange, G., Playford, D., Stewart, S., Celermajer, D. (2023). The prognostic significance of stroke volume index in low gradient severe aortic stenosis: from the national echo database of Australia. International Journal of Cardiovascular Imaging, 39(9), 1719-1727. [More Information]

2022

• Offen, S., Playford, D., Strange, G., Stewart, S., Celermajer, D. (2022). Adverse Prognostic Impact of Even Mild or Moderate Tricuspid Regurgitation: Insights from the National Echocardiography Database of Australia. Journal of the American Society of Echocardiography, 35(8), 810-817. [More Information]
• Brida, M., Chessa, M., Celermajer, D., Li, W., Geva, T., Khairy, P., Griselli, M., Gatzoulis, M., Gatzoulis, M. (2022). Atrial septal defect in adulthood: a new paradigm for congenital heart disease. European Heart Journal, 43(28), 2660-2671. [More Information]
• Kott, K., Bishop, M., Yang, C., Plasto, T., Cheng, D., Kaplan, A., Cullen, L., Celermajer, D., Meikle, P., Vernon, S., Figtree, G. (2022). Biomarker Development in Cardiology: Reviewing the Past to Inform the Future. Cells, 11(3), 588. [More Information]
• Toro, C., Felmingham, B., Jessop, S., Celermajer, D., Kotecha, R., Govender, D., Terese Hanna, D., O'Connor, M., Manudhane, R., Ayer, J., O'Sullivan, J., et al (2022). Cardio-Oncology Recommendations for Pediatric Oncology Patients: An Australian and New Zealand Delphi Consensus. JACC: Advances, 1(5). [More Information]
• Lam, Y., Tan, R., Michael, P., Yang, N., Dunn, L., Cooke, J., Celermajer, D., Wise, S., Ng, M. (2022). Endothelial thioredoxin interacting protein (TXNIP) modulates endothelium-dependent vasorelaxation in hyperglycemia. Microvascular research, 143. [More Information]
• Tran, D., Gibson, H., Maiorana, A., Verrall, C., Baker, D., Clode, M., Lubans, D., Zannino, D., Bullock, A., Ferrie, S., Gosbell, S., Davis, G., Keech, A., Puranik, R., Majumdar, A., Ayer, J., Celermajer, D., Cordina, R., et al (2022). Exercise Intolerance, Benefits, and Prescription for People Living With a Fontan Circulation: The Fontan Fitness Intervention Trial (F-FIT)—Rationale and Design. Frontiers in Pediatrics, 9, 799125. [More Information]
• Cao, J., Marathe, S., Zannino, D., Celermajer, D., Justo, R., Alphonso, N., D'Udekem, Y., Winlaw, D. (2022). Fontan operation at less than 3 years of age is not a risk factor for long-term failure. European Journal Of Cardio-Thoracic Surgery, 61(3), 497-504. [More Information]
• Vernon, S., Kott, K., Hansen, T., Finemore, M., Baumgart, K., Bhindi, R., Yang, J., Hansen, P., Nicholls, S., Celermajer, D., Ward, M., Van Nunen, S., Grieve, S., Figtree, G. (2022). Immunoglobulin E Sensitization to Mammalian Oligosaccharide Galactose-á-1,3 (á-Gal) Is Associated With Noncalcified Plaque, Obstructive Coronary Artery Disease, and ST-Segment-Elevated Myocardial Infarction. Arteriosclerosis, Thrombosis, and Vascular Biology, 42(3), 352-361. [More Information]
• Daley, M., Buratto, E., King, G., Grigg, L., Iyengar, A., Alphonso, N., Bullock, A., Celermajer, D., Ayer, J., Robertson, T., et al (2022). Impact of Fontan Fenestration on Long-Term Outcomes: A Propensity Score–Matched Analysis. Journal of the American Heart Association, 11(11). [More Information]
• Lim, M., Cordina, R., Kotchetkova, I., Celermajer, D. (2022). Late complication rates after aortic coarctation repair in patients with or without a bicuspid aortic valve. Heart, 108(11), 855-859. [More Information]
• Borlaug, B., Blair, J., Bergmann, M., Bugger, H., Burkhoff, D., Bruch, L., Celermajer, D., Claggett, B., Cleland, J., Cutlip, D., et al (2022). Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure. Circulation, 145(21), 1592-1604. [More Information]
• Stanton, K., Kienzle, V., Dinnes, D., Kotchetkov, I., Jessup, W., Kritharides, L., Celermajer, D., Rye, K. (2022). Moderate-and High-Intensity Exercise Improves Lipoprotein Profile and Cholesterol Efflux Capacity in Healthy Young Men. Journal of the American Heart Association, 11(12). [More Information]
• King, G., Buratto, E., Celermajer, D., Grigg, L., Alphonso, N., Robertson, T., Bullock, A., Ayer, J., Iyengar, A., D'udekem, Y., et al (2022). Natural and Modified History of Atrioventricular Valve Regurgitation in Patients With Fontan Circulation. Journal of the American College of Cardiology, 79(18), 1832-1845. [More Information]
• Figtree, G., Adamson, P., Antoniades, C., Blumenthal, R., Blaha, M., Budoff, M., Celermajer, D., Chan, M., Chow, C., Dey, D., Giannotti, N., Grieve, S., Patel, S., Vernon, S., et al (2022). Noninvasive Plaque Imaging to Accelerate Coronary Artery Disease Drug Development. Circulation, 146(22), 1712-1727. [More Information]
• Lim, M., Portelli, S., Padang, R., Bannon, P., Hambly, B., Jeremy, R., Celermajer, D., Robertson, E. (2022). Novel insights into bicuspid aortic valve (BAV) aortopathy: Long non-coding RNAs TUG1 and MIAT are differentially expressed in BAV ascending aortas. Cardiovascular Pathology, 60, 10743-1-10743-4. [More Information]
• Othman, F., Bailey, B., Collins, N., Lau, E., Tanous, D., Rao, K., Celermajer, D., Cordina, R. (2022). Platypnea-Orthodeoxia Syndrome in the Setting of Patent Foramen Ovale Without Pulmonary Hypertension or Major Lung Disease. Journal of the American Heart Association, 11(15). [More Information]
• Offen, S., Baker, D., Puranik, R., Celermajer, D. (2022). Right ventricular volume and its relationship to functional tricuspid regurgitation. IJC Heart & Vasculature, 38, 100940. [More Information]
• Stanton, K., Wylie, L., Kotchetkova, I., Coy, A., Carroll, G., La Gerche, A., Celermajer, D. (2022). Soldiers' Heart: A Prospective Study of Cardiac Remodeling in Soldiers Undergoing Progressive Intensity Exercise Training. Medicine and Science in Sports and Exercise, 54(12), 2011-2019. [More Information]
• Lawley, C., Tanous, D., O'Donnell, C., Anderson, B., Aroney, N., Walters, D., Shipton, S., Wilson, W., Celermajer, D., Roberts, P. (2022). Ten Years of Percutaneous Pulmonary Valve Implantation in Australia and New Zealand. Heart, Lung, and Circulation, 31(12), 1649-1657. [More Information]
• Marshall, K., D'udekem, Y., Winlaw, D., Dalziel, K., Woolfenden, S., Zannino, D., Costa, D., Bishop, R., Celermajer, D., Sholler, G., et al (2022). The Australian and New Zealand Fontan Registry Quality of Life Study: Protocol for a population-based assessment of quality of life among people with a Fontan circulation, their parents, and siblings. BMJ Open, 12(9). [More Information]
• Woo, K., Chan, S., Kwok, T., Yin, Y., Chook, P., Lin, C., Celermajer, D. (2022). The Different Impact of PM2.5 on Atherogenesis in Overseas vs. Native Chinese in the CATHAY Study. Atmosphere, 13(8). [More Information]
• Stanton, K., Liu, H., Kienzle, V., Bursill, C., Bao, S., Celermajer, D. (2022). The Effects of Exercise on Plaque Volume and Composition in a Mouse Model of Early and Late Life Atherosclerosis. Frontiers in Cardovascular Medicine, 9. [More Information]

2021

• Baker, D., Celermajer, D. (2021). Acute aortic dissection as a late and fatal complication of transcatheter persistent ductus arteriosus occlusion: a case report. European Heart Journal - Case Reports, 5(1), ytaa484. [More Information]
• Rehan, R., Kotchetkova, I., Cordina, R., Celermajer, D. (2021). Adult Congenital Heart Disease Survivors at Age 50 Years: Medical and Psychosocial Status. Heart, Lung, and Circulation, 30(2), 261-266. [More Information]
• Cai, T., Mosalman Haghighi, M., Roberts, P., Mervis, J., Qasem, A., Butlin, M., Celermajer, D., Avolio, A., Skilton, M., Ayer, J. (2021). Assessment of Central Arterial Hemodynamics in Children: Comparison of Noninvasive and Invasive Measurements. American Journal of Hypertension, 34(2), 163-171. [More Information]
• Khandkar, C., Madhavan, M., Weaver, J., Celermajer, D., Karimi Galougahi, K. (2021). Atherothrombosis in Acute Coronary Syndromes-From Mechanistic Insights to Targeted Therapies. Cells, 10(4), 865-1-865-18. [More Information]
• Lim, M., Celermajer, D., Bannon, P. (2021). Bicuspid aortic valve disease – the influence of valve morphotype on age at and types of surgical treatment. IJC Heart & Vasculature, 34. [More Information]
• Dissanayake, H., McMullan, R., Kong, Y., Caterson, I., Celermajer, D., Phang, M., Raynes-Greenow, C., Polson, J., Gordon, A., Skilton, M. (2021). Cardiac and vascular health in late preterm infants (In Press). Journal of Developmental Origins of Health and Disease, 13(1), 128-134. [More Information]
• Snir, A., Ng, M., Strange, G., Playford, D., Stewart, S., Celermajer, D. (2021). Cardiac Damage Staging Classification Predicts Prognosis in All the Major Subtypes of Severe Aortic Stenosis: Insights from the National Echo Database Australia. Journal of the American Society of Echocardiography, 34(11), 1137-1147. [More Information]
• Strange, G., Playford, D., Scalia, G., Celermajer, D., Prior, D., Codde, J., Chan, Y., Bulsara, M., Stewart, S. (2021). Change in ejection fraction and long-term mortality in adults referred for echocardiography. European Journal of Heart Failure, 23(4), 555-563. [More Information]
• Lim, M., Strange, G., Playford, D., Stewart, S., Celermajer, D. (2021). Characteristics of bicuspid aortic valve disease and stenosis: The national echo database of Australia. Journal of the American Heart Association, 10(17), e020785-1-e020785-16. [More Information]
• Puranik, R., Tann, O., Occleshaw, C., Celermajer, D., Grigg, L., Bullock, A., Chen, S., Ugander, M., Cordina, R., Ayer, J. (2021). CMRI in Congenital Heart Disease Patients: Concerns Over Patient Safety Because of Inadequate Accreditation Procedures for MRI Scanning and Reporting. Heart, Lung, and Circulation, 30(8), e86-e87. [More Information]
• Lee, T., D'Souza, K., Hameed, A., Yao, J., Lam, S., Chadban, S., Ying, T., Celermajer, D., Sandroussi, C., Pleass, H., et al (2021). Comparison of the effect of single vs dual antiplatelet agents on post-operative haemorrhage after renal transplantation: A systematic review and meta-analysis. Transplantation Reviews, 35(1), 100594. [More Information]
• Tran, D., Rodrigues, C., du Plessis, K., Zannino, D., Davis, G., Celermajer, D., d'Udekem, Y., Cordina, R. (2021). Decline Is Not Inevitable: Exercise Capacity Trajectory in an Australian and New Zealand Fontan Cohort. Heart, Lung, and Circulation, 30(9), 1356-1363. [More Information]
• Playford, D., Strange, G., Celermajer, D., Evans, G., Scalia, G., Stewart, S., Prior, D. (2021). Diastolic dysfunction and mortality in 436360 men and women: the National Echo Database Australia (NEDA). European Heart Journal - Cardiovascular Imaging, 22(5), 505-515. [More Information]
• Koay, Y., Stanton, K., Kienzle, V., Li, M., Yang, J., Celermajer, D., O'Sullivan, J. (2021). Effect of chronic exercise in healthy young male adults: a metabolomic analysis. Cardiovascular Research, 117(2), 613-622. [More Information]
• Stewart, S., Playford, D., Scalia, G., Currie, P., Celermajer, D., Prior, D., Codde, J., Strange, G. (2021). Ejection fraction and mortality: a nationwide register-based cohort study of 499 153 women and men. European Journal of Heart Failure, 23(3), 406-416. [More Information]
• Tran, D., Maiorana, A., Davis, G., Celermajer, D., D'Udekem, Y., Cordina, R. (2021). Exercise Testing and Training in Adults With Congenital Heart Disease: A Surgical Perspective. Annals of Thoracic Surgery, 112(4), 1045-1054. [More Information]
• Cao, J., Tran, D., Briody, J., Attard, C., Hassan, E., Simm, P., Burchill, L., Twigg, S., Fiatarone Singh, M., Ayer, J., Celermajer, D., Cordina, R., et al (2021). Impact of adiposity on clinical outcomes in people living with a Fontan circulation. International Journal of Cardiology, 329, 82-88. [More Information]
• Tran, D., Munoz, P., Lau, E., Alison, J., Brown, M., Zheng, Y., Corkery, P., Wong, K., Lindstrom, S., Celermajer, D., Davis, G., Cordina, R. (2021). Inspiratory Muscle Training Improves Inspiratory Muscle Strength and Functional Exercise Capacity in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: A Pilot Randomised Controlled Study. Heart, Lung, and Circulation, 30(3), 388-395. [More Information]
• Femia, J., Zhu, D., Choudhary, P., Ross, S., Muthurangu, V., Richmond, D., Celermajer, D., Semsarian, C., Puranik, R. (2021). Long term clinical outcomes associated with CMR quantified isolated left ventricular non-compaction in adults. International Journal of Cardiology, 328, 235-240. [More Information]
• Choudhary, P., Strugnell, W., Puranik, R., Hamilton-Craig, C., Kutty, S., Celermajer, D. (2021). LV non-compaction in patients with coarctation of the aorta: prevalence and effects on cardiac function. Cardiology in the Young, 31(9), 1445-1450. [More Information]
• Chami, J., Nicholson, C., Strange, G., Cordina, R., Celermajer, D. (2021). National and regional registries for congenital heart diseases: Strengths, weaknesses and opportunities. International Journal of Cardiology, 338, 89-94. [More Information]
• Verrall, C., Yang, J., Chen, J., Schembri, A., D'Udekem, Y., Zannino, D., Kasparian, N., du Plessis, K., Grieve, S., Welton, T., Celermajer, D., et al (2021). Neurocognitive Dysfunction and Smaller Brain Volumes in Adolescents and Adults with a Fontan Circulation. Circulation, 143(9), 878-891. [More Information]
• Snir, A., Wilson, M., Ju, L., Zhao, Y., Wong, S., Khor, L., Naoum, C., Wong, K., Keech, A., Celermajer, D., Ng, M. (2021). Novel Pressure-Regulated Deployment Strategy for Improving the Safety and Efficacy of Balloon-Expandable Transcatheter Aortic Valves. J A C C: Cardiovascular Interventions, 14(22), 2503-2515. [More Information]
• Baker, D., Dennis, M., Zannino, D., Schilling, C., Moreno, P., Bullock, A., Disney, P., Radford, D., Hornung, T., Grigg, L., Ayer, J., Celermajer, D., Cordina, R., et al (2021). Path ahead for € low risk' adolescents living with a Fontan circulation. Heart, 107(7), 556-562. [More Information]
• Marijon, E., Mocumbi, A., Narayanan, K., Jouven, X., Celermajer, D. (2021). Persisting burden and challenges of rheumatic heart disease. European Heart Journal, 42(34), 3338-3348. [More Information]
• Poh, C., Cordina, R., Iyengar, A., Zannino, D., Grigg, L., Wheaton, G., Bullock, A., Ayer, J., Alphonso, N., Gentles, T., Celermajer, D., et al (2021). Pre- and Post-operative determinants of transplantation-free survival after Fontan. The Australia and New Zealand experience. IJC Heart & Vasculature, 35, 100825. [More Information]
• Snir, A., Ng, M., Strange, G., Playford, D., Stewart, S., Celermajer, D. (2021). Prevalence and outcomes of low-gradient severe aortic stenosis—from the national echo database of Australia. Journal of the American Heart Association, 10(22), e021126. [More Information]
• Sharma, V., Iyengar, A., Zannino, D., Gentles, T., Justo, R., Celermajer, D., Bullock, A., Winlaw, D., Wheaton, G., Burchill, L., et al (2021). Protein-losing enteropathy and plastic bronchitis after the Fontan procedure. Journal of Thoracic and Cardiovascular Surgery, 161(6), 2158-2.17E+07. [More Information]
• Sree Raman, K., Shah, R., Stokes, M., Walls, A., Woodman, R., Perry, R., Walker, J., Proudman, S., De Pasquale, C., Celermajer, D., et al (2021). Right ventricular myocardial deoxygenation in patients with pulmonary artery hypertension. Journal of Cardiovascular Magnetic Resonance, 23(1), 22. [More Information]
• Rubenis, I., Tran, D., Bullock, A., Wijesekera, V., Baker, D., D'udekem, Y., du Plessis, K., Katz, D., Lowy, M., Zentner, D., Celermajer, D., Cordina, R. (2021). Sexual Function in Men Living With a Fontan Circulation. Frontiers in Pediatrics, 9, 765380. [More Information]
• Lapirow, D., La Gerche, A., Toro, C., Masango, E., Costello, B., Porello, E., Ludlow, L., Marshall, G., Trahair, T., Mateos, M., Byrne, J., Celermajer, D., et al (2021). The Australia and New Zealand Cardio-Oncology Registry: evaluation of chemotherapy-related cardiotoxicity in a national cohort of paediatric cancer patients. Internal Medicine Journal, 51(2), 229-234. [More Information]
• Woo, K., Lin, C., Yin, Y., Guo, D., Chook, P., Kwok, T., Celermajer, D. (2021). The impact of air pollution (Pm2.5) on atherogenesis in modernizing southern versus northern China. Atmosphere, 12(12), 1552. [More Information]
• Woo, K., Chook, P., Hu, Y., Lao, X., Lin, C., Lee, P., Kwok, C., Wei, A., Guo, D., Yin, Y., Celermajer, D., et al (2021). The impact of particulate matter air pollution (PM2.5) on atherosclerosis in modernizing China: a report from the CATHAY study. International Journal of Epidemiology, 50(2), 578-588. [More Information]
• Tran, D., Celermajer, D., Ayer, J., Grigg, L., Clendenning, C., Hornung, T., Justo, R., Davis, G., D'Udekem, Y., Cordina, R. (2021). The “Super-Fontan” Phenotype: Characterizing Factors Associated With High Physical Performance. Frontiers in Cardovascular Medicine, 8. [More Information]
• Chami, J., Strange, G., Nicholson, C., Celermajer, D. (2021). Towards a Unified Coding System for Congenital Heart Diseases. Circulation: Cardiovascular Quality and Outcomes, 14(7), e008216. [More Information]

2020

• Barraclough, J., Joglekar, M., Januszewski, A., Martínez, G., Celermajer, D., Keech, A., Hardikar, A., Patel, S. (2020). A MicroRNA Signature in Acute Coronary Syndrome Patients and Modulation by Colchicine. Journal of Cardiovascular Pharmacology and Therapeutics, 25(5), 444-455. [More Information]
• Gondoputro, W., Rajendran, S., Celermajer, D., Qasabian, R. (2020). An unusual case of upper limb ischemia in a marathon runner. Journal of Vascular Surgery Cases and Innovative Techniques, 6(1), 160-164. [More Information]
• Lam, M., Hsu, C., Simpson, P., Dunn, L., Chow, R., Chan, K., Yong, A., Yu, Y., Sieveking, D., Lecce (Venuto), L., Celermajer, D., Wise, S., Ng, M., et al (2020). Androgens Stimulate EPC-Mediated Neovascularization and Are Associated with Increased Coronary Collateralization. Endocrinology, 161(5), 1-13. [More Information]
• Lim, M., Bannon, P., Celermajer, D. (2020). Bicuspid aortic valve: Different clinical profiles for subjects with versus without repaired aortic coarctation. Open Heart, 7(2), 574. [More Information]
• Tran, D., D'Ambrosio, P., Verrall, C., Attard, C., Briody, J., D'Souza, M., Fiatarone Singh, M., Ayer, J., d'Udekem, Y., Twigg, S., Davis, G., Celermajer, D., Cordina, R. (2020). Body Composition in Young Adults Living With a Fontan Circulation: The Myopenic Profile. Journal of the American Heart Association, 9, 1-15. [More Information]
• Moore, B., Cao, J., Cordina, R., McGuire, M., Celermajer, D. (2020). Defibrillators in adult congenital heart disease: Long-term risk of appropriate shocks, inappropriate shocks, and complications. Pacing And Clinical Electrophysiology, 43(7), 746-753. [More Information]
• Khou, V., Anderson, J., Strange, G., Corrigan, C., Collins, N., Celermajer, D., Dwyer, N., Feenstra, J., Horrigan, M., Keating, D., Lau, E., et al (2020). Diagnostic delay in pulmonary arterial hypertension: Insights from the Australian and New Zealand pulmonary hypertension registry. Respirology, 25(8), 863-871. [More Information]
• Cai, T., Qasem, A., Butlin, M., Aviolo, A., Ayer, J., Celermajer, D., Skilton, M. (2020). Effect of body habitus and heart rate on accuracy of aortic-radial transfer functions for predicting central hemodynamic indices in growing children. Artery Research, 26(4), 242-249. [More Information]
• Khuong, J., Wilson, T., Grigg, L., Bullock, A., Celermajer, D., Disney, P., Wijesekera, V., Hornung, T., Zannino, D., Iyengar, A., et al (2020). Fontan-associated nephropathy: Predictors and outcomes. International Journal of Cardiology, 306, 73-77. [More Information]
• Marshall, K., d'Udekem, Y., Sholler, G., Opotowsky, A., Costa, D., Sharpe, L., Celermajer, D., Winlaw, D., Newburger, J., Kasparian, N. (2020). Health-Related Quality of Life in Children, Adolescents, and Adults With a Fontan Circulation: A Meta-Analysis. Journal of the American Heart Association, 9(6), e014172. [More Information]
• Marathe, S., Zannino, D., Cao, J., du Plessis, K., Marathe, S., Ayer, J., Celermajer, D., Gentles, T., Sholler, G., Justo, R., Winlaw, D., et al (2020). Heterotaxy Is Not a Risk Factor for Adverse Long-Term Outcomes After Fontan Completion. Annals of Thoracic Surgery, 110(2), 646-653. [More Information]
• Celermajer, D., Offen, S. (2020). Is vWF really a very wonderful factor for risk stratification in adults with congenital heart disease? Heart, 106(12), 876-877. [More Information]
• Raman, K., Shah, R., Stokes, M., Walls, A., Woodman, R., Ananthakrishna, R., Walker, J., Proudman, S., Steele, P., De Pasquale, C., Celermajer, D., et al (2020). Left ventricular ischemia in pre-capillary pulmonary hypertension: a cardiovascular magnetic resonance study. Cardiovascular Diagnosis and Therapy, 10(5), 1280-1292. [More Information]
• Femia, J., Semsarian, C., Ross, S., Celermajer, D., Puranik, R. (2020). Left ventricular non-compaction: Review of the current diagnostic challenges and consequences in athletes. Medicina, 56(12), 1-10. [More Information]
• Opotowsky, A., Celermajer, D., Rhodes, J. (2020). Letter by Opotowsky et al Regarding Article, "results of the FUEL Trial". Circulation, 142(4), E38-E39. [More Information]
• Strange, G., Stewart, S., Farthing, M., Kasparian, N., Selbie, L., O'Donnell, C., Ayer, J., Cordina, R., Celermajer, D. (2020). Living With, and Caring for, Congenital Heart Disease in Australia: Insights From the Congenital Heart Alliance of Australia and New Zealand Online Survey. Heart, Lung, and Circulation, 29(2), 216-223. [More Information]
• Waldmann, V., Karam, N., Rischard, J., Bougouin, W., Sharifzadehgan, A., Dumas, F., Narayanan, K., Sideris, G., Voicu, S., Gandjbakhch, E., Celermajer, D., et al (2020). Low rates of immediate coronary angiography among young adults resuscitated from sudden cardiac arrest. Resuscitation, 147, 34-42. [More Information]
• Zentner, D., Celermajer, D., Gentles, T., d'Udekem, Y., Ayer, J., Blue, G., Bridgman, C., Burchill, L., Cheung, M., Cordina, R., McGuire, M., Moore, B., Sholler, G., Winlaw, D., et al (2020). Management of People With a Fontan Circulation: a Cardiac Society of Australia and New Zealand Position statement. Heart, Lung, and Circulation, 29(1), 5-39. [More Information]
• Arnott, C., Nelson, M., Alfaro Ramirez, M., Hyett, J., Gale, M., Henry, A., Celermajer, D., Taylor, L., Woodward, M. (2020). Maternal cardiovascular risk after hypertensive disorder of pregnancy. Heart, 106(24), 1927-1933. [More Information]
• Poh, C., Hornung, T., Celermajer, D., Radford, D., Justo, R., Andrews, D., du Plessis, K., Iyengar, A., Winlaw, D., d'Udekem, Y. (2020). Modes of late mortality in patients with a Fontan circulation. Heart, 106(18), 1427-1431. [More Information]
• Skilton, M., Celermajer, D. (2020). Noninvasive Assessment of Arterial Structure and Function. In Not known (Eds.), Pediatric and Congenital Cardiology, Cardiac Surgery and Intensive Care, (pp. 1-16). TBC. [More Information]
• Marathe, S., Cao, J., Celermajer, D., Ayer, J., Sholler, G., d'Udekem, Y., Winlaw, D. (2020). Outcomes of the Fontan Operation for Patients With Heterotaxy: A Meta-Analysis of 848 Patients. Annals of Thoracic Surgery, 110(1), 307-315. [More Information]
• Moore, B., Medi, C., McGuire, M., Celermajer, D., Cordina, R. (2020). Pacing-associated cardiomyopathy in adult congenital heart disease. Open Heart, 7(2), e001374. [More Information]
• Anderson, J., Lavender, M., Lau, E., Celermajer, D., Collins, N., Dwyer, N., Feenstra, J., Horrigan, M., Keating, D., Keogh, A., et al (2020). Pharmacological Treatment of Pulmonary Arterial Hypertension in Australia: Current Trends and Challenges. Heart, Lung, and Circulation, 29(10), 1459-1468. [More Information]
• Playford, D., Stewart, S., Celermajer, D., Prior, D., Scalia, G., Marwick, T., Ilton, M., Codde, J., Strange, G. (2020). Poor Survival with Impaired Valvular Hemodynamics After Aortic Valve Replacement: The National Echo Database Australia Study. Journal of the American Society of Echocardiography, 33(9), 1077-1086.e1. [More Information]
• Ratwatte, S., Anderson, J., Strange, G., Corrigan, C., Collins, N., Celermajer, D., Dwyer, N., Feenstra, J., Keating, D., Kotlyar, E., Lau, E., et al (2020). Pulmonary arterial hypertension with below threshold pulmonary vascular resistance. European Respiratory Journal, 56(1), 1901654. [More Information]
• Levin, R., Carnegie, M., Celermajer, D. (2020). Pulse Pressure: An Emerging Therapeutic Target for Dementia. Frontiers in Neuroscience, 14. [More Information]
• Tran, D., Maiorana, A., Ayer, J., Lubans, D., Davis, G., Celermajer, D., d'Udekem, Y., Cordina, R. (2020). Recommendations for exercise in adolescents and adults with congenital heart disease. Progress In Cardiovascular Diseases, 63(3), 350-366. [More Information]
• Cao, J., Wales, K., Zhao, D., Seco, M., Celermajer, D., Bannon, P. (2020). Repair of Less Than Severe Tricuspid Regurgitation during Left Sided Valve Surgery: A Meta-Analysis. Annals of Thoracic Surgery, 109(3), 950-958. [More Information]
• Anderson, J., Lau, E., Lavender, M., Benza, R., Celermajer, D., Collins, N., Corrigan, C., Dwyer, N., Feenstra, J., Horrigan, M., et al (2020). Retrospective Validation of the REVEAL 2.0 Risk Score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort. Chest, 157(1), 162-172. [More Information]
• Rashid, I., Mahmood, A., Ismail, T., O'Meagher, S., Kutty, S., Celermajer, D., Puranik, R. (2020). Right ventricular systolic dysfunction but not dilatation correlates with prognostically significant reductions in exercise capacity in repaired Tetralogy of Fallot. European Heart Journal - Cardiovascular Imaging, 21(8), 906-913. [More Information]
• Kay, S., Moore, B., Seco, M., Marshman, D., Grieve, S., Celermajer, D. (2020). Rugby Player's Aorta: Alarming Prevalence of Ascending Aortic Dilatation and Effacement in Elite Rugby Players. Heart, Lung, and Circulation, 29(2), 196-201. [More Information]
• Nanayakkara, B., Lau, E., Yee, B., Gauthier, G., Melehan, K., Celermajer, D., Cordina, R. (2020). Sleep disordered breathing in adults living with a Fontan circulation and CPAP titration protocol. International Journal of Cardiology, 317, 70-74. [More Information]
• Woo, K., Hu, Y., Chook, P., Wei, A., Wu, M., Li, L., Woo, J., Chan, T., Cheng, W., Celermajer, D. (2020). The Impact of Lifestyle Changes on Cardiometabolic Health in Modernizing China: A Tale of Three Gorges in the Yangtze River. Metabolic Syndrome and Related Disorders, 18(1), 65-71. [More Information]
• Gatzoulis, M., Brida, M., Celermajer, D. (2020). The new european heart journal congenital heart disease team. European Heart Journal, 41(43), 4157-4158. [More Information]
• Waldmann, V., Combes, N., Ladouceur, M., Celermajer, D., Iserin, L., Gatzoulis, M., Khairy, P., Marijon, E. (2020). Understanding Electrocardiography in Adult Patients With Congenital Heart Disease: A Review. JAMA Cardiology, 5(12), 1435-1444. [More Information]
• Cai, T., Meroni, A., Dissanayake, H., Phang, M., Aviolo, A., Celermajer, D., Butlin, M., Skilton, M., Qasem, A. (2020). Validation of a cuff-based device for measuring carotid-femoral pulse wave velocity in children and adolescents. Journal of Human Hypertension, 34(4), 311-318. [More Information]
• Tarp, J., Clausen, P., Celermajer, D., Christoffersen, C., Jensen, A., Sørensen, K., Sillesen, H., Estensen, M., Nagy, E., Holstein-Rathlou, N., et al (2020). Vascular function in adults with cyanotic congenital heart disease. IJC Heart & Vasculature, 30, 100632. [More Information]
• Arnott, C., Patel, S., Hyett, J., Jennings, G., Woodward, M., Celermajer, D. (2020). Women and Cardiovascular Disease: Pregnancy, the Forgotten Risk Factor. Heart, Lung, and Circulation, 29(5), 662-667. [More Information]
• Baker, D., Celermajer, D. (2020). Would increasing stress on the heart decrease stress on the doctor? Decision-making in asymptomatic pulmonary regurgitation. Heart, 107(3), 180-182. [More Information]

2019

• Woo, K., Hu, Y., Chook, P., Wei, A., Chan, R., Yin, Y., Celermajer, D. (2019). A Tale of Three Gorges in the Yangtze River: Comparing the Prevalence of Metabolic Syndrome According to ATPIII, WHO, and IDF Criteria and the Association with Vascular Health in Modernizing China. Metabolic Syndrome and Related Disorders, 17(3), 137-142. [More Information]
• Nicolae, M., Gentles, T., Strange, G., Tanous, D., Disney, P., Bullock, A., Grigg, L., Chen, S., Pressley, L., Cordina, R., Celermajer, D., et al (2019). Adult Congenital Heart Disease in Australia and New Zealand A Call for Optimal Care. Heart, Lung, and Circulation, 28(4), 521-529. [More Information]
• Callaghan, F., Bannon, P., Barin, E., Celermajer, D., Jeremy, R., Figtree, G., Grieve, S. (2019). Age-related changes of shape and flow dynamics in healthy adult aortas: A 4D flow MRI study. Journal of Magnetic Resonance Imaging, 49(1), 90-100. [More Information]
• King, G., Ayer, J., Celermajer, D., Zentner, D., Justo, R., Disney, P., Zannino, D., d’Udekem, Y. (2019). Atrioventricular Valve Failure in Fontan Palliation. Journal of the American College of Cardiology, 73(7), 810-822. [More Information]
• Shearer, L., Justo, R., Marathe, S., Betts, K., Venugopal, P., Winlaw, D., Bullock, A., Robertson, T., Gentles, T., Celermajer, D., et al (2019). Augmentation of the pulmonary arteries at or prior to the Fontan procedure is not associated with worse long-term outcomes: a propensity-matched analysis from the Australia-New Zealand Fontan Registry. European Journal Of Cardio-Thoracic Surgery, 55(5), 829-836. [More Information]
• Kott, K., Vernon, S., Hansen, T., Yu, C., Bubb, K., Coffey, S., Sullivan, D., Yang, J., O'Sullivan, J., Chow, C., Patel, S., Chong, J., Celermajer, D., Kritharides, L., Grieve, S., Figtree, G. (2019). Biobanking for discovery of novel cardiovascular biomarkers using imaging-quantified disease burden: protocol for the longitudinal, prospective, BioHEART-CT cohort study. BMJ Open, 9(9), 1-9. [More Information]
• Jouven, X., Diop, B., Narayanan, K., Adoubi, A., Ba, S., Balde, D., Damorou, J., Diarra, M., Dzudie, A., Ferreira, B., Celermajer, D., et al (2019). Cardiac Pacing in Sub-Saharan Africa: JACC International. Journal of the American College of Cardiology, 74(21), 2652-2660. [More Information]
• Chiesa, S., Masi, S., Shipley, M., Ellins, E., Fraser, A., Hughes, A., Patel, R., Khir, A., Halcox, J., Singh-Manoux, A., Celermajer, D., et al (2019). Carotid artery wave intensity in mid- to late-life predicts cognitive decline: the Whitehall II study. European Heart Journal, 40(28), 2300-2309. [More Information]
• Gallagher, R., Chow, C., Parker, H., Neubeck, L., Celermajer, D., Redfern, J., Tofler, G., Buckley, T., Schumacher, T., Ferry, C., Whitley, A., Figtree, G., et al (2019). Design and rationale of the MyHeartMate study: a randomised controlled trial of a game-based app to promote behaviour change in patients with cardiovascular disease. BMJ Open, 9(5), 1-7. [More Information]
• Barraclough, J., Skilton, M., Garden, F., Toelle, B., Marks, G., Celermajer, D. (2019). Early and late childhood telomere length predict subclinical atherosclerosis at age 14 yrs. - The CardioCAPS study. International Journal of Cardiology, 278, 250-253. [More Information]
• Moore, B., Cordina, R., McGuire, M., Celermajer, D. (2019). Efficacy and adverse effects of sotalol in adults with congenital heart disease. International Journal of Cardiology, 274, 74-79. [More Information]
• Raman, K., Stokes, M., Walls, A., Perry, R., Steele, P., Burdeniuk, C., De Pasquale, C., Celermajer, D., Selvanayagam, J. (2019). Feasibility of oxygen sensitive cardiac magnetic resonance of the right ventricle in pulmonary artery hypertension. Cardiovascular Diagnosis and Therapy, 9(5), 502-512. [More Information]
• Simonneau, G., Montani, D., Celermajer, D., Denton, C., Gatzoulis, M., Krowka, M., Williams, P., Souza, R. (2019). Haemodynamic definitions and updated clinical classification of pulmonary hypertension. European Respiratory Journal, 53(1), 1-13. [More Information]
• Dennis, M., Cusick, A., Borilovic, J., Nicholson, C., Derwin, T., Puranik, R., Celermajer, D. (2019). Left arm structure and function late after subclavian flap repair of aortic coarctation in childhood. Cardiology in the Young, 29(7), 856-861. [More Information]
• Choudhary, P., Strugnell, W., Puranik, R., Hamilton-Craig, C., Kutty, S., Celermajer, D. (2019). Left ventricular non-compaction in patients with single ventricle heart disease. Cardiology in the Young, 30(1), 12-18. [More Information]
• Skilton, M., Celermajer, D., Cosmi, E., Crispi, F., Gidding, S., Raitakari, O., Urbina, E. (2019). Natural History of Atherosclerosis and Abdominal Aortic Intima-Media Thickness: Rationale, Evidence, and Best Practice for Detection of Atherosclerosis in the Young. Journal of Clinical Medicine, 8(8), 1-20. [More Information]
• Poh, C., Celermajer, D., Grigg, L., Kalman, J., McGuire, M., Gentles, T., Radford, D., Bullock, A., Disney, P., Winlaw, D., et al (2019). Pacemakers are associated with a higher risk of late death and transplantation in the Fontan population. International Journal of Cardiology, 282, 33-37. [More Information]
• Strange, G., Stewart, S., Celermajer, D., Prior, D., Scalia, G., Marwick, T., Ilton, M., Joseph, M., Codde, J., Playford, D. (2019). Poor Long-term Survival in Patients with Moderate Aortic Stenosis. Journal of the American College of Cardiology, 74(15), 1851-1863. [More Information]
• D'Ambrosio, P., Tran, D., Verrall, C., Attard, C., Fiatarone Singh, M., Ayer, J., d'Udekem, Y., Twigg, S., Celermajer, D., Cordina, R. (2019). Prevalence and risk factors for low bone density in adults with a Fontan circulation. Congenital Heart Disease, 14(6), 987-995. [More Information]
• Gnappa, G., Celermajer, D., Zhu, D., Puranik, R., Ayer, J. (2019). Severe right ventricular dilatation after repair of Tetralogy of Fallot is associated with increased left ventricular preload and stroke volume. European Heart Journal - Cardiovascular Imaging, 20(9), 1020-1026. [More Information]
• Cordina, R., Playford, D., Lang, I., Celermajer, D. (2019). State-of-the-Art Review: Echocardiography in Pulmonary Hypertension. Heart, Lung, and Circulation, 28(9), 1351-1364. [More Information]
• Tarp, J., Sorgaard, M., Christoffersen, C., Jensen, A., Sillesen, H., Celermajer, D., Eriksson, P., Estensen, M., Nagy, E., Holstein-Rathlou, N., et al (2019). Subclinical atherosclerosis in patients with cyanotic congenital heart disease. International Journal of Cardiology, 277, 97-103. [More Information]
• James, N., Milijasevic, Z., Ujhazy, A., Edwards, G., Jermyn, K., Mynard, J., Celermajer, D. (2019). The common carotid artery provides significant pressure wave dampening in the young adult sheep. IJC Heart & Vasculature, 23. [More Information]
• Witte, K., Lipiecki, J., Siminiak, T., Meredith, I., Malkin, C., Goldberg, S., Stark, M., von Bardeleben, R., Cremer, P., Jaber, W., Celermajer, D., et al (2019). The REDUCE FMR Trial: A Randomized Sham-Controlled Study of Percutaneous Mitral Annuloplasty in Functional Mitral Regurgitation. JACC: Heart Failure, 7(11), 945-955. [More Information]
• Strange, G., Stewart, S., Celermajer, D., Prior, D., Scalia, G., Marwick, T., Gabbay, E., Ilton, M., Joseph, M., Codde, J., et al (2019). Threshold of Pulmonary Hypertension Associated With Increased Mortality. Journal of the American College of Cardiology, 73(21), 2660-2672. [More Information]
• Wang, N., Fulcher, J., Abeysuriya, N., McGrady, M., Wilcox, I., Celermajer, D., Lal, S. (2019). Tricuspid regurgitation is associated with increased mortality independent of pulmonary pressures and right heart failure: a systematic review and meta-analysis. European Heart Journal, 40(5), 476-484. [More Information]
• Barraclough, J., Garden, F., Toelle, B., Marks, G., Baur, L., Ayer, J., Celermajer, D. (2019). Weight Gain Trajectories from Birth to Adolescence and Cardiometabolic Status in Adolescence. The Journal of Pediatrics, 208, 89-95.e4. [More Information]

2018

• Moore, B., Anderson, R., Nisbet, A., Kalla, M., du Plessis, K., d'Udekem, Y., Bullock, A., Cordina, R., Grigg, L., Celermajer, D., McGuire, M., et al (2018). Ablation of Atrial Arrhythmias After the Atriopulmonary Fontan Procedure: Mechanisms of Arrhythmia and Outcomes. JACC: Clinical Electrophysiology, 4(10), 1338-1346. [More Information]
• Moore, B., Cordina, R., McGuire, M., Celermajer, D. (2018). Adverse effects of amiodarone therapy in adults with congenital heart disease. Congenital Heart Disease, 13(6), 944-951. [More Information]
• Celermajer, D. (2018). Atrial septal defects: Even simple congenital heart diseases can be complicated. European Heart Journal, 39(12), 999-1001. [More Information]
• Dissanayake, H., McMullan, R., Kong, Y., Caterson, I., Celermajer, D., Phang, M., Raynes-Greenow, C., Polson, J., Gordon, A., Skilton, M. (2018). Body Fatness and Cardiovascular Health in Newborn Infants. Journal of Clinical Medicine, 7(9), 1-12. [More Information]
• O'Brien, E., Law, D., Celermajer, D., Grant, P., Waites, J. (2018). Caring for adults with congenital heart disease in a regional setting. Australian Journal of Rural Health, 26(6), 441-446. [More Information]
• Yu, C., Moore, B., Kotchetkova, I., Cordina, R., Celermajer, D. (2018). Causes of death in a contemporary adult congenital heart disease cohort. Heart, 104(20), 1678-1682. [More Information]
• Chong, L., Fitzgerald, D., Craig, J., Manera, K., Hanson, C., Celermajer, D., Ayer, J., Kasparian, N., Jaure, A. (2018). Children's experiences of congenital heart disease: a systematic review of qualitative studies. European Journal of Pediatrics, 177(3), 319-336. [More Information]
• Dennis, M., Zannino, D., du Plessis, K., Bullock, A., Disney, P., Radford, D., Hornung, T., Grigg, L., Cordina, R., d'Udekem, Y., Celermajer, D. (2018). Clinical Outcomes in Adolescents and Adults After the Fontan Procedure. Journal of the American College of Cardiology, 71(9), 1009-1017. [More Information]
• Garden, F., Toelle, B., Mihrshahi, S., Webb, K., Almqvist, C., Tovey, E., Brew, B., Ayer, J., Skilton, M., Jones, G., Cowie, C., Britton, W., Celermajer, D., Leeder, S., Peat, J., Marks, G., et al (2018). Cohort profile: The Childhood Asthma Prevention Study (CAPS). International Journal of Epidemiology, 47(6), 1736a-1736k. [More Information]
• Vaidya, K., Arnott, C., Martinez, G., Ng, B., McCormack, S., Sullivan, D., Celermajer, D., Patel, S. (2018). Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome: A CT Coronary Angiography Study. JACC: Cardiovascular Imaging, 11(2), 305-316. [More Information]
• Vaidya, K., Khandkar, C., Celermajer, D. (2018). Current management aspects in adult congenital heart disease: Non-surgical closure of patent foramen ovale. Cardiovascular Diagnosis and Therapy, 8(6), 739-753. [More Information]
• Cao, J., Lee, S., Phan, K., Ayer, J., Celermajer, D., Winlaw, D. (2018). Early Outcomes of Hypoplastic Left Heart Syndrome Infants: Meta-Analysis of Studies Comparing the Hybrid and Norwood Procedures. World Journal for Pediatric and Congenital Heart Surgery, 9(2), 224-233. [More Information]
• Cordina, R., Ministeri, M., Babu-Narayan, S., Ladouceur, M., Celermajer, D., Gatzoulis, M., Uebing, A., Li, W. (2018). Evaluation of the relationship between ventricular end-diastolic pressure and echocardiographic measures of diastolic function in adults with a Fontan circulation. International Journal of Cardiology, 259, 71-75. [More Information]
• Wong, J., Chabiniok, R., Tibby, S., Pushparajah, K., Sammut, E., Celermajer, D., Giese, D., Hussain, T., Greil, G., Schaeffter, T., et al (2018). Exploring kinetic energy as a new marker of cardiac function in the single ventricle circulation. Journal of Applied Physiology, 125(3), 889-900. [More Information]
• Harmer, J., Keech, A., Veillard, A., Skilton, M., Watts, G., Celermajer, D. (2018). Fenofibrate effects on carotid artery intima-media thickness in adults with type 2 diabetes mellitus: a FIELD substudy. Diabetes Research and Clinical Practice, 141, 156-167. [More Information]
• Marijon, E., Celermajer, D., Jouven, X. (2018). Global Burden of Rheumatic Heart Disease. New England Journal of Medicine, 378(1), e2. [More Information]
• Lal, S., Kotchetkova, I., Cao, J., Jackson, D., Cordina, R., Celermajer, D. (2018). Heart failure admissions and poor subsequent outcomes in adults with congenital heart disease. European Journal of Heart Failure, 20(4), 812-815. [More Information]
• Wilson, T., d'Udekem, Y., Winlaw, D., Cordina, R., Celermajer, D., Wheaton, G., Bullock, A., Gentles, T., Weintraub, R., Justo, R., Ayer, J., et al (2018). Hepatic and renal end-organ damage in the Fontan circulation: A report from the Australian and New Zealand Fontan Registry. International Journal of Cardiology, 273, 100-107. [More Information]
• Neidenbach, R., Niwa, K., Oto, O., Oechslin, E., Aboulhosn, J., Celermajer, D., Schelling, J., Pieper, L., Sanftenberg, L., Oberhoffer, R., et al (2018). Improving medical care and prevention in adults with congenital heart disease—reflections on a global problem—part I: Development of congenital cardiology, epidemiology, clinical aspects, heart failure, cardiac arrhythmia. Cardiovascular Diagnosis and Therapy, 8(6), 705-715. [More Information]
• Neidenbach, R., Niwa, K., Oto, O., Oechslin, E., Aboulhosn, J., Celermajer, D., Schelling, J., Pieper, L., Sanftenberg, L., Oberhoffer, R., et al (2018). Improving medical care and prevention in adults with congenital heart disease—reflections on a global problem—part II: Infective endocarditis, pulmonary hypertension, pulmonary arterial hypertension and aortopathy. Cardiovascular Diagnosis and Therapy, 8(6), 716-724. [More Information]
• Gerges, C., Gerges, M., Fesler, P., Pistritto, A., Konowitz, N., Jakowitsch, J., Celermajer, D., Lang, I. (2018). In-depth hemodynamic phenotyping of pulmonary hypertension due to left heart disease. European Respiratory Journal, 51(5), 1-12. [More Information]
• Moore, B., Yu, C., Kotchetkova, I., Cordina, R., Celermajer, D. (2018). Incidence and clinical characteristics of sudden cardiac death in adult congenital heart disease. International Journal of Cardiology, 254, 101-106. [More Information]
• Spencer, L., Zafiropoulos, B., Denniss, W., Fowler, D., Alison, J., Celermajer, D. (2018). Is there a learning effect when the 6-minute walk test is repeated in people with suspected pulmonary hypertension? Chronic Respiratory Disease, 15(4), 339-346. [More Information]
• Chung, K., Strange, G., Codde, J., Celermajer, D., Scalia, G., Playford, D. (2018). Left Heart Disease and Pulmonary Hypertension: Are We Seeing the Full Picture? Heart, Lung, and Circulation, 27(3), 301-309. [More Information]
• Cao, J., Phan, K., Ayer, J., Celermajer, D., Winlaw, D. (2018). Long term survival of hypoplastic left heart syndrome infants: Meta-analysis comparing outcomes from the modified Blalock–Taussig shunt and the right ventricle to pulmonary artery shunt. International Journal of Cardiology, 254, 107-116. [More Information]
• Dennis, M., Kotchetkova, I., Cordina, R., Celermajer, D. (2018). Long-Term Follow-up of Adults Following the Atrial Switch Operation for Transposition of the Great Arteries - A Contemporary Cohort. Heart, Lung, and Circulation, 27(8), 1011-1017. [More Information]
• Elias, P., Poh, C., du Plessis, K., Zannino, D., Rice, K., Radford, D., Bullock, A., Wheaton, G., Celermajer, D., d’Udekem, Y. (2018). Long-term outcomes of single-ventricle palliation for pulmonary atresia with intact ventricular septum: Fontan survivors remain at risk of late myocardial ischaemia and death. European Journal Of Cardio-Thoracic Surgery, 53(6), 1230-1236. [More Information]
• Cordina, R., Celermajer, D., d’Udekem, Y. (2018). Lower limb exercise generates pulsatile flow into the pulmonary vascular bed in the setting of the Fontan circulation. Cardiology in the Young, 28(5), 732-733. [More Information]
• Cordina, R., Ahmad, S., Kotchetkova, I., Eveborn, G., Pressley, L., Ayer, J., Chard, R., Tanous, D., Robinson, P., Kilian, J., Celermajer, D., et al (2018). Management errors in adults with congenital heart disease: prevalence, sources, and consequences. European Heart Journal, 39(12), 982-989. [More Information]
• Dissanayake, H., McMullan, R., Gordon, A., Caterson, I., Celermajer, D., Phang, M., Raynes-Greenow, C., Skilton, M., Polson, J. (2018). Noninvasive assessment of autonomic function in human neonates born at the extremes of fetal growth spectrum. Physiological Reports, 6(8), e13682. [More Information]
• Tran, D., Lau, E., Celermajer, D., Davis, G., Cordina, R. (2018). Pathophysiology of exercise intolerance in pulmonary arterial hypertension. Respirology, 23(2), 148-159. [More Information]
• Cao, J., Wales, K., Cordina, R., Lau, E., Celermajer, D. (2018). Pulmonary vasodilator therapies are of no benefit in pulmonary hypertension due to left heart disease: A meta-analysis. International Journal of Cardiology, 273, 213-220. [More Information]
• Arnott, C., Strange, G., Bullock, A., Kirby, A., O'Donnell, C., Radford, D., Grigg, L., Celermajer, D. (2018). Pulmonary vasodilator therapy is associated with greater survival in Eisenmenger syndrome. Heart, 104(9), 732-737. [More Information]
• Melehan, K., Hoyos, C., Hamilton, G., Wong, K., Yee, B., McLachlan, R., O'Meagher, S., Celermajer, D., Ng, M., Grunstein, R., et al (2018). Randomised trial of CPAP and Vardenafil on erectile and arterial function in men with obstructive sleep apnea and erectile dysfunction. The Journal of Clinical Endocrinology and Metabolism, 103(4), 1601-1611. [More Information]
• Li, A., Celermajer, D., Chan, M., Sung, R., Woo, K. (2018). Reference range for brachial artery flow-mediated dilation in healthy Chinese children and adolescents. Hong Kong Medical Journal, 24 Suppl 3(3), 36-38.
• Cao, J., Lee, S., Phan, K., Celermajer, D., Lal, S. (2018). Renin-angiotensin-aldosterone inhibition improves right ventricular function: a meta-analysis. Heart Asia, 10(1), 1-7. [More Information]
• Martinez, G., Celermajer, D., Patel, S. (2018). Reply to: Inhibitory effects of colchicine on inflammasomes"". Atherosclerosis, 273, 155-156. [More Information]
• Gnanappa, G., Rashid, I., Celermajer, D., Ayer, J., Puranik, R. (2018). Reproducibility of Cardiac Magnetic Resonance Imaging (CMRI)-Derived Right Ventricular Parameters in Repaired Tetralogy of Fallot (ToF). Heart, Lung, and Circulation, 27(3), 381-385. [More Information]
• Morton, J., Bao, B., Vanags, L., Tsatralis, T., Ridiandries, A., Siu, C., Ng, K., Tan, J., Celermajer, D., Ng, M., Bursill, C. (2018). Strikingly Different Atheroprotective Effects of Apolipoprotein A-I in Early-Versus Late-Stage Atherosclerosis. JACC: Basic to Translational Science, 3(2), 187-199. [More Information]
• Skoro-Sajer, N., Gerges, C., Hajnalka Balint, O., Kohalmi, D., Kaldararova, M., Simkova, I., Jakowitsch, J., Gabriel, H., Baumgartner, H., Gerges, M., Celermajer, D., et al (2018). Subcutaneous treprostinil in congenital heart disease-related pulmonary arterial hypertension. Heart, 104(14), 1195-1199. [More Information]
• Strange, G., Lau, E., Giannoulatou, E., Corrigan, C., Kotlyar, E., Kermeen, F., Williams, T., Celermajer, D., Dwyer, N., Whitford, H., et al (2018). Survival of Idiopathic Pulmonary Arterial Hypertension Patients in the Modern Era in Australia and New Zealand. Heart, Lung, and Circulation, 27(11), 1368-1375. [More Information]
• Arnott, C., Cordina, R., Celermajer, D. (2018). The Echocardiographic Characteristics and Prognostic Significance of Pericardial Effusions in Eisenmenger Syndrome. Heart, Lung, and Circulation, 27(3), 394-396. [More Information]
• Nasir-Ahmad, S., Cordina, R., Liew, G., McCluskey, P., Celermajer, D. (2018). The eye in CHD. Cardiology in the Young, 28(8), 981-985. [More Information]
• Strange, G., Celermajer, D., Marwick, T., Prior, D., Ilton, M., Codde, J., Scalia, G., Stewart, S., Bulsara, M., Gabbay, E., et al (2018). The National Echocardiography Database Australia (NEDA): Rationale and methodology. American Heart Journal, 204, 186-189. [More Information]
• Martinez, G., Celermajer, D., Patel, S. (2018). The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation. Atherosclerosis, 269, 262-271. [More Information]
• Choteau, S., Cuesta Torres, L., Barraclough, J., Elder, A., Martinez, G., Chen Fan, W., Shrestha, S., Ong, K., Barter, P., Celermajer, D., et al (2018). Transcoronary gradients of HDL-associated MicroRNAs in unstable coronary artery disease. International Journal of Cardiology, 253, 138-144. [More Information]
• Skoro-Sajer, N., Gerges, C., Gerges, M., Panzenbock, A., Jakowitsch, J., Kurz, A., Taghavi, S., Sadushi-Kolici, R., Campean, I., Klepetko, W., Celermajer, D., et al (2018). Usefulness of thrombosis and inflammation biomarkers in chronic thromboembolic pulmonary hypertension—sampling plasma and surgical specimens. Journal Of Heart And Lung Transplantation, 37(9), 1067-1074. [More Information]

2017

• Indraratna, P., Alexopoulos, C., Celermajer, D., Alford, K. (2017). Acute ST-Elevation Myocardial Infarction, a Unique Complication of Recreational Nitrous Oxide Use. Heart, Lung, and Circulation, 26(8), e41-e43. [More Information]
• Dennis, M., Moore, B., Kotchetkova, I., Pressley, L., Cordina, R., Celermajer, D. (2017). Adults with repaired tetralogy: Low mortality but high morbidity up to middle age. Open Heart, 4(1), 1-6. [More Information]
• Cai, T., Qasem, A., Ayer, J., Butlin, M., O'Meagher, S., Melki, C., Marks, G., Avolio, A., Celermajer, D., Skilton, M. (2017). Central blood pressure in children and adolescents: non-invasive development and testing of novel transfer functions. Journal of Human Hypertension, 31(12), 831-837. [More Information]
• Celermajer, D., Nasir-Ahmad, S. (2017). Cigarette smoking in Austria - a call for action. Wiener Klinische Wochenschrift, 129(23-24), 864-865. [More Information]
• Bhaskar, S., Cordato, D., Cappelen-Smith, C., Cheung, A., Ledingham, D., Celermajer, D., Levi, C. (2017). Clarion call for histopathological clot analysis in "cryptogenic" ischemic stroke: implications for diagnosis and treatment. Annals of Clinical and Translational Neurology, 4(12), 926-930. [More Information]
• McMullan, R., Fuller, N., Caterson, I., Celermajer, D., Gordon, A., Hespe, C., Hyett, J., O'Reilly, C., Phipps, H., Skilton, M. (2017). Developmental Origins of Health and Disease: Who knows? Who cares? Journal of Paediatrics and Child Health, 53(6), 613-614. [More Information]
• Celermajer, D. (2017). Eisenmenger syndrome: A rare malady that continues to fascinate. European Heart Journal, 38(26), 2068-2069. [More Information]
• Cistulli, P., Celermajer, D. (2017). Endothelial Dysfunction and Obstructive Sleep Apnea: The Jury Is Still Out!. American Journal of Respiratory and Critical Care Medicine, 195(9), 1135-1137. [More Information]
• Lau, E., Giannoulatou, E., Celermajer, D., Humbert, M. (2017). Epidemiology and treatment of pulmonary arterial hypertension. Nature Reviews Cardiology, 14(10), 603-614. [More Information]
• Huang, L., Dalziel, K., Schilling, C., Celermajer, D., McNeil, J., Winlaw, D., Gentles, T., Radford, D., Cheung, M., Bullock, A., et al (2017). Hospital costs and cost implications of co-morbid conditions for patients with single ventricle in the period through to Fontan completion. International Journal of Cardiology, 240, 178-182. [More Information]
• Huang, L., Schilling, C., Dalziel, K., Xie, S., Celermajer, D., McNeil, J., Winlaw, D., Hornung, T., Radford, D., Grigg, L., et al (2017). Hospital Inpatient Costs for Single Ventricle Patients Surviving the Fontan Procedure. American Journal of Cardiology, 120(3), 467-472. [More Information]
• Moore, B., Cao, J., Kotchetkova, I., Celermajer, D. (2017). Incidence, predictors and outcomes of infective endocarditis in a contemporary adult congenital heart disease population. International Journal of Cardiology, 249, 161-165. [More Information]
• Vernon, S., Coffey, S., Bhindi, R., Hoo, S., Nelson, G., Ward, M., Hansen, P., Asrress, K., Chow, C., Celermajer, D., O'Sullivan, J., Figtree, G. (2017). Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained by standard modifiable risk factors. European Journal of Preventive Cardiology, 24(17), 1824-1830. [More Information]
• Laohachai, K., Winlaw, D., Selvadurai, H., Gnanappa, G., d’Udekem, Y., Celermajer, D., Ayer, J. (2017). Inspiratory muscle training is associated with improved inspiratory muscle strength, resting cardiac output, and the ventilatory efficiency of exercise in patients with a fontan circulation. Journal of the American Heart Association, 6(8), 1-11. [More Information]
• Liu, J., Drak, D., Krishnan, A., Chen, S., Canniffe, C., Bao, B., Denyer, G., Celermajer, D. (2017). Left Ventricular Fibrosis and Systolic Hypertension Persist in a Repaired Aortic Coarctation Model. Annals of Thoracic Surgery, 104(3), 942-949. [More Information]
• Karam, N., Narayanana, K., Bougouin, W., Benameur, N., Beganton, F., Jost, D., Lamhaut, L., Perier, M., Cariou, A., Celermajer, D., et al (2017). Major Regional Differences in Automated External Defibrillator Placement and Basic Life Support Training in France: Further Needs for Coordinated Implementation. Resuscitation, 118, 49-54. [More Information]
• Martinez, G., Barraclough, J., Nakhla, S., Kienzle, V., Robertson, S., Mallat, Z., Celermajer, D., Patel, S. (2017). Neutrophil-derived microparticles are released into the coronary circulation following percutaneous coronary intervention in acute coronary syndrome patients. Bioscience Reports, 37(1), 1-11. [More Information]
• Ne, J., Cai, T., Celermajer, D., Caterson, I., Gill, T., Lee, C., Skilton, M. (2017). Obesity, arterial function and arterial structure - a systematic review and meta-analysis. Obesity Science & Practice, 3(2), 171-184. [More Information]
• Moonen, A., Garsia, R., Youssef, P., Torzillo, P., Corte, T., Boehm, C., Cordina, R., Celermajer, D., Lau, E. (2017). Outcomes of pulmonary arterial hypertension therapy in Australia: is monotherapy adequate? Internal Medicine Journal, 47(10), 1124-1128. [More Information]
• Kapellas, K., Mejia, G., Bartold, P., Skilton, M., Maple-Brown, L., Slade, G., O’Dea, K., Brown, A., Celermajer, D., Jamieson, L. (2017). Periodontal therapy and glycaemic control among individuals with type 2 diabetes: reflections from the PerioCardio study. International Journal of Dental Hygiene, 15(4), e42-e51. [More Information]
• Bougouin, W., Marijon, E., Planquette, B., Karam, N., Dumas, F., Celermajer, D., Jost, D., Lamhaut, L., Beganton, F., Cariou, A., et al (2017). Pulmonary embolism related sudden cardiac arrest admitted alive at hospital: Management and outcomes. Resuscitation, 115, 135-140. [More Information]
• Callaghan, F., Arnott, C., Figtree, G., Kutty, S., Celermajer, D., Grieve, S. (2017). Quantifying right atrial filling and emptying: A 4D-flow MRI study. Journal of Magnetic Resonance Imaging, 45(4), 1046-1054. [More Information]
• Callaghan, F., Arnott, C., Figtree, G., Kutty, S., Celermajer, D., Grieve, S. (2017). Quantifying right atrial filling and emptying: A 4D-flow MRI study. Journal of Magnetic Resonance Imaging, 45(4), 1-1. [More Information]
• McKenzie, K., Dissanayake, H., McMullan, R., Caterson, I., Celermajer, D., Gordon, A., Hyett, J., Meroni, A., Phang, M., Raynes-Greenow, C., Polson, J., Skilton, M. (2017). Quantity and Quality of Carbohydrate Intake during Pregnancy, Newborn Body Fatness and Cardiac Autonomic Control: Conferred Cardiovascular Risk? Nutrients, 9(12), 1-12. [More Information]
• Marijon, E., Celermajer, D., Jouven, X. (2017). Rheumatic heart disease — An iceberg in tropical waters. New England Journal of Medicine, 377(8), 780-781. [More Information]
• Lau, E., Celermajer, D., Keogh, A., Thakkar, V. (2017). Screening of Pulmonary Arterial Hypertension. Seminars in Respiratory and Critical Care Medicine, 38(5), 596-605. [More Information]
• Barraclough, J., Garden, F., Toelle, B., O'Meagher, S., Marks, G., Cowell, C., Celermajer, D., Ayer, J. (2017). Sex differences in aortic augmentation index in adolescents. Journal of Hypertension, 35(10), 2016-2024. [More Information]
• Morrisroe, K., Stevens, W., Huq, M., Prior, D., Sahhar, J., Ngian, G., Celermajer, D., Zochling, J., Proudman, S., Nikpour, M. (2017). Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension. Arthritis Research and Therapy, 19(1), 1-10. [More Information]
• Gnanappa, G., Celermajer, D., Sholler, G., Gentles, T., Winlaw, D., d'Udekem, Y., Ayer, J. (2017). The Long-Term Management of Children and Adults with a Fontan Circulation: A Systematic Review and Survey of Current Practice in Australia and New Zealand. Pediatric Cardiology, 38, 56-69. [More Information]
• Stanton, K., Ganigara, M., Corte, P., Celermajer, D., McGuire, M., Torzillo, P., Corte, T., Puranik, R. (2017). The Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Cardiac Sarcoidosis. Heart, Lung, and Circulation, 26(11), 1191-1199. [More Information]
• Poh, C., Zannino, D., Weintraub, R., Winlaw, D., Grigg, L., Cordina, R., Hornung, T., Bullock, A., Justo, R., Gentles, T., Celermajer, D., et al (2017). Three decades later: The fate of the population of patients who underwent the Atriopulmonary Fontan procedure. International Journal of Cardiology, 231, 99-104. [More Information]
• Skilton, M., Yeo, S., Ne, J., Celermajer, D., Caterson, I., Lee, C. (2017). Weight Loss and Carotid Intima-Media Thickness-A Meta-Analysis. Obesity, 25(2), 357-362. [More Information]

2016

• Krishnan, A., Drak, D., Bao, B., Celermajer, D., Liu, J. (2016). A model of early transient pressure overload simulating repair of aortic coarctation in childhood. Journal of Thoracic and Cardiovascular Surgery, 151(6), 1766-1768. [More Information]
• Cai, T., Magnussen, C., Haluska, B., Johnson, D., Mottram, P., Isbel, N., Celermajer, D., Marwick, T., Skilton, M. (2016). Carotid extra-medial thickness does not predict adverse cardiovascular outcomes in high-risk adults. Diabetes and Metabolism, 42(3), 200-203. [More Information]
• Cai, T., Sullivan, T., Ayer, J., Harmer, J., Leeder, S., Toelle, B., Marks, G., Celermajer, D., Skilton, M. (2016). Carotid extramedial thickness is associated with local arterial stiffness in children. Journal of Hypertension, 34(1), 109-115. [More Information]
• Robertson, S., Martinez, G., Payet, C., Barraclough, J., Celermajer, D., Bursill, C., Patel, S. (2016). Colchicine Therapy in Acute Coronary Syndrome Patients acts on Caspase-1 to Suppress NLRP3 Inflammasome Monocyte Activation. Clinical Science, 130(14), 1237-1246. [More Information]
• Celermajer, D., Strange, G., Cordina, R., Selbie, L., Sholler, G., Winlaw, D., Alphonso, N., Justo, R., Nicholae, M., Kasparian, N., et al (2016). Congenital Heart Disease Requires a Lifetime Continuum of Care: A call for a Regional Registry. Heart, Lung, and Circulation, 25(8), 750-754. [More Information]
• Offen, S., Jackson, D., Canniffe, C., Choudhary, P., Celermajer, D. (2016). Dextrocardia in Adults with Congenital Heart Disease. Heart, Lung, and Circulation, 25(4), 352-357. [More Information]
• Kizirian, N., Kong, Y., Muirhead, R., Brodie, S., Garnett, S., Petocz, P., Sim, K., Celermajer, D., Louie, J., Markovic, T., Ross, G., Brand-Miller, J., Skilton, M., et al (2016). Effects of a low-glycemic index diet during pregnancy on offspring growth, body composition, and vascular health: A pilot randomized controlled trial. American Journal of Clinical Nutrition, 103(4), 1073-1082. [More Information]
• Chia, E., Lau, E., Xuan, W., Celermajer, D., Thomas, L. (2016). Exercise testing can unmask right ventricular dysfunction in systemic sclerosis patients with normal resting pulmonary artery pressure. International Journal of Cardiology, 204, 179-186. [More Information]
• Bougouin, W., Marijon, E., Planquette, B., Karam, N., Dumas, F., Celermajer, D., Jost, D., Lamhaut, L., Beganton, F., Cariou, A., et al (2016). Factors Associated With Pulmonary Embolism-Related Sudden Cardiac Arrest. Circulation, 134(25), 2125-2127. [More Information]
• Amarasena, N., Kapellas, K., Skilton, M., Maple-Brown, L., Brown, A., Bartold, M., O'Dea, K., Celermajer, D., Jamieson, L. (2016). Factors associated with routine dental attendance among aboriginal Australians. Journal of Health Care for the Poor and Underserved, 27(1), 67-80. [More Information]
• Wright, L., Dwyer, N., Celermajer, D., Kritharides, L., Marwick, T. (2016). Follow-Up of Pulmonary Hypertension With Echocardiography. JACC: Cardiovascular Imaging, 9(6), 733-746. [More Information]
• Tan, J., Prosser, H., Dunn, L., Vanags, L., Ridiandries, A., Tsatralis, T., Leece, L., Clayton, Z., Yuen, S., Robertson, S., Lam, M., Celermajer, D., Ng, M., Bursill, C. (2016). High Density Lipoproteins Rescue Diabetes-Impaired Angiogenesis via Scavenger Receptor Class B Type I. Diabetes, 65(10), 3091-3103. [More Information]
• Kapadia, R., Choudhary, P., Collins, N., Celermajer, D., Puranik, R. (2016). Left Ventricular Non-compaction in Holt-Oram Syndrome. Heart, Lung, and Circulation, 25(6), 626-630. [More Information]
• Nikpour, M., Prior, D., Celermajer, D. (2016). Letter by Nikpour et al regarding article, "Effect of warfarin treatment on survival of patients with Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)". Circulation, 133(20), e661. [More Information]
• Cairns, T., Shi, W., Iyengar, A., Nisbet, A., Forsdick, V., Zannino, D., Gentles, T., Radford, D., Justo, R., Celermajer, D., Winlaw, D., et al (2016). Long-term outcomes after first-onset arrhythmia in Fontan physiology. Journal of Thoracic and Cardiovascular Surgery, 152(5), 1355-1363.e1. [More Information]
• Lau, E., Chemla, D., Godinas, L., Zhu, K., Sitbon, O., Savale, L., Montani, D., Jais, X., Celermajer, D., Simonneau, G., et al (2016). Loss of Vascular Distensibility During Exercise is an Early Hemodynamic Marker of Pulmonary Vascular Disease. Chest, 149(2), 353-361. [More Information]
• Clift, P., Celermajer, D. (2016). Managing adult Fontan patients: where do we stand? European Respiratory Review, 25(142), 438-450. [More Information]
• Calderone, A., Stevens, W., Prior, D., Nandurkar, H., Gabbay, E., Proudman, S., Williams, T., Celermajer, D., Sahhar, J., Wong, P., et al (2016). Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol. BMJ Open, 6(12), 1-12. [More Information]
• Neubeck, A., Gallagher, R., Ingram, K., Celermajer, D., Schumacher, T., Ferry, K., Buckley, T., Redfern, J., Chow, C., Tofler, G., Figtree, G. (2016). MyHeartMate: Development of a Digital Game to Improve Secondary Prevention of Cardiovascular Disease. Abstracts for the 64th Cardiac Society of Australia and New Zealand Annual Scientific Meeting and the International Society for Heart Research Australasian Section Annual Scientific Meeting, Adelaide: Elsevier.
• Iyengar, A., Winlaw, D., Galati, J., Wheaton, G., Gentles, T., Grigg, L., Justo, R., Radford, D., Attard, C., Weintraub, R., Sholler, G., Celermajer, D., et al (2016). No difference between aspirin and warfarin after extracardiac Fontan in a propensity score analysis of 475 patients. European Journal Of Cardio-Thoracic Surgery, 50(5), 980-987. [More Information]
• Hansen, T., Galougahi, K., Celermajer, D., Rasko, N., Tang, O., Bubb, K., Figtree, G. (2016). Oxidative and Nitrosative Signalling in Pulmonary Arterial Hypertension- Implications for Development of Novel Therapies. Pharmacology & Therapeutics, 165, 50-62. [More Information]
• Seneviratne, M., Grieve, S., Figtree, G., Garsia, R., Celermajer, D., Adelstein, S., Puranik, R. (2016). Prevalence, distribution and clinical correlates of myocardial fibrosis in systemic lupus erythematosus: a cardiac magnetic resonance study. Lupus, 25(6), 573-581. [More Information]
• Lau, E., Godinas, L., Sitbon, O., Montani, D., Savale, L., Jais, X., Lador, F., Gunther, S., Celermajer, D., Simonneau, G., et al (2016). Resting pulmonary artery pressure of 21-24 mmHg predicts abnormal exercise haemodynamics. European Respiratory Journal, 47(5), 1436-1444. [More Information]
• Wright, L., Dwyer, N., Power, J., Kritharides, L., Celermajer, D., Marwick, T. (2016). Right Ventricular Systolic Function Responses to Acute and Chronic Pulmonary Hypertension: Assessment with Myocardial Deformation. Journal of the American Society of Echocardiography, 29(3), 259-266. [More Information]
• Kutty, S., Rathod, R., Danford, D., Celermajer, D. (2016). Role of imaging in the evaluation of single ventricle with the Fontan palliation. Heart, 102(3), 174-183. [More Information]
• Choudhary, P., Nandakumar, R., Greig, H., Broadhurst, P., Dean, J., Puranik, R., Celermajer, D., Hillis, G. (2016). Structural and electrical cardiac abnormalities are prevalent in asymptomatic adults with myotonic dystrophy. Heart, 102(18), 1472-1478. [More Information]
• McCombe, A., Touma, F., Jackson, D., Canniffe, C., Choudhary, P., Pressley, L., Tanous, D., Robinson, P., Celermajer, D. (2016). Sudden cardiac death in adults with congenitally corrected transposition of the great arteries. Open Heart, 3(2), 1-7. [More Information]
• Arnott, C., Boehm, C., Lau, E., Celermajer, D. (2016). Survival outcomes in severe congenital versus non-congenital pulmonary hypertension. Heart Asia, 8(1), 3-7. [More Information]
• Skilton, M., Nakhla, S., Ayer, J., Harmer, J., Toelle, B., Leeder, S., Jones, G., Marks, G., Celermajer, D. (2016). Telomere length in early childhood: Early life risk factors and association with carotid intima-media thickness in later childhood. European Journal of Preventive Cardiology, 23(10), 1086-1092. [More Information]
• Poh, C., Cochrane, A., Galati, J., Bullock, A., Celermajer, D., Gentles, T., du Plessis, K., Winlaw, D., Hornung, T., Finucane, K., et al (2016). Ten-year outcomes of Fontan conversion in Australia and New Zealand demonstrate the superiority of a strategy of early conversion. European Journal Of Cardio-Thoracic Surgery, 49(2), 530-535. [More Information]
• Brown, R., Celermajer, D., Macefield, V., Sander, M. (2016). The Effect of Nitric Oxide Inhibition in Spinal Cord Injured Humans with and without Preserved Sympathetic Control of the Vasculature. Frontiers in Neuroscience, 10, 1-8. [More Information]
• Schilling, C., Dalziel, K., Nunn, R., du Plessis, K., Shi, W., Celermajer, D., Winlaw, D., Weintraub, R., Grigg, L., Radford, D., et al (2016). The Fontan epidemic: Population projections from the Australia and New Zealand Fontan Registry. International Journal of Cardiology, 219, 14-19. [More Information]
• Grimaldi, A., Mocumbi, A., Freers, J., Lachaud, M., Mirabel, M., Ferreira, B., Narayanan, K., Celermajer, D., Sidi, D., Jouven, X., et al (2016). Tropical Endomyocardial Fibrosis: Natural History, Challenges, and Perspectives. Circulation, 133(24), 2503-2515. [More Information]
• Wilson, T., Iyengar, A., Winlaw, D., Weintraub, R., Wheaton, G., Gentles, T., Ayer, J., Grigg, L., Justo, R., Radford, D., Celermajer, D., et al (2016). Use of ACE inhibitors in Fontan: Rational or irrational? International Journal of Cardiology, 210, 95-99. [More Information]
• Callaghan, F., Kozor, R., Sherrah, A., Vallely, M., Celermajer, D., Figtree, G., Grieve, S. (2016). Use of multi-velocity encoding 4D flow MRI to improve quantification of flow patterns in the aorta. Journal of Magnetic Resonance Imaging, 43(2), 352-363. [More Information]
• Iyengar, A., Celermajer, D., Winlaw, D., d'Udekem, Y. (2016). Young and Free: Over 25 Years of Seminal Contributions to Complex Congenital Heart Disease From Australia & New Zealand. Heart, Lung, and Circulation, 25(6), 529-534. [More Information]

2015

• Strange, G., Rose, M., Kermeen, F., O'Donnell, C., Keogh, A., Kotlyar, E., Grigg, L., Bullock, A., Disney, P., Dwyer, N., Celermajer, D., et al (2015). A binational registry of adults with pulmonary arterial hypertension complicating congenital heart disease. Internal Medicine Journal, 45(9), 944-950. [More Information]
• Jogia, D., Liang, M., Lin, Z., Celermajer, D. (2015). A Potential Echocardiographic Classification for Constrictive Pericarditis Based on Analysis of Abnormal Septal Motion. Journal of cardiovascular ultrasound, 23(3), 143-149. [More Information]
• Amarasena, N., Kapellas, K., Skilton, M., Maple-Brown, L., Brown, A., O’Dea, K., Celermajer, D., Jamieson, L. (2015). Associations with dental caries experience among a convenience sample of Aboriginal Australian adults. Australian Dental Journal, 60(4), 471-478. [More Information]
• Yu, Y., Wise, S., Celermajer, D., Bilek, M., Ng, M. (2015). Bioengineering stents with proactive biocompatibility. Interventional Cardiology, 7(6), 571-584. [More Information]
• Yu, Y., Wise, S., Michael, P., Bax, D., Yuen, G., Hiob, M., Yeo, G., Filipe, E., Dunn, L., Chan, K., Mollahajian, H., Celermajer, D., Weiss, A., Ng, M. (2015). Characterization of Endothelial Progenitor Cell Interactions with Human Tropoelastin. PloS One, 10(6), 1-16. [More Information]
• Martinez, G., Robertson, S., Barraclough, J., Xia, Q., Mallat, Z., Bursill, C., Celermajer, D., Patel, S. (2015). Colchicine Acutely Suppresses Local Cardiac Production of Inflammatory Cytokines in Patients With an Acute Coronary Syndrome. Journal of the American Heart Association, 4(8), 1-10. [More Information]
• Sharma, T., Lau, E., Choudhary, P., Torzillo, P., Munoz, P., Simmons, L., Naeije, R., Celermajer, D. (2015). Dobutamine stress for evaluation of right ventricular reserve in pulmonary arterial hypertension. European Respiratory Journal, 45(3), 700-708. [More Information]
• Lau, E., Humbert, M., Celermajer, D. (2015). Early detection of pulmonary arterial hypertension. Nature Reviews Cardiology, 12(3), 143-155. [More Information]
• Luu, Q., Choudhary, P., Jackson, D., Canniffe, C., McGuire, M., Chard, R., Celermajer, D. (2015). Ebstein's Anomaly in Those Surviving to Adult Life - A Single Centre Experience. Heart, Lung, and Circulation, 24(10), 996-1001. [More Information]
• Padang, R., Ganigara, M., O'Meagher, S., Grieve, S., Bannon, P., Celermajer, D., Jeremy, R., Semsarian, C., Puranik, R. (2015). Feasibility of using real-time CMR imaging to evaluate acute thoracic aortic response to exercise. International Journal of Cardiology, 197, 306-308. [More Information]
• Harmer, J., Keech, A., Veillard, A., Skilton, M., Marwick, T., Watts, G., Meredith, I., Celermajer, D. (2015). Fenofibrate effects on arterial endothelial function in adults with type 2 diabetes mellitus: A FIELD substudy. Atherosclerosis, 242(1), 295-302. [More Information]
• Bougouin, W., Mustafic, H., Marijon, E., Murad, M., Dumas, F., Barbouttis, A., Jabre, P., Beganton, F., Empana, J., Celermajer, D., et al (2015). Gender and survival after sudden cardiac arrest: A systematic review and meta-analysis. Resuscitation, 94, 55-60. [More Information]
• Choudhary, P., Hsu, C., Grieve, S., Smillie, C., Singarayar, S., Semsarian, C., Richmond, D., Muthurangu, V., Celermajer, D., Puranik, R. (2015). Improving the diagnosis of LV non-compaction with cardiac magnetic resonance imaging. International Journal of Cardiology, 181, 430-436. [More Information]
• Choudhary, P., Canniffe, C., Jackson, D., Tanous, D., Walsh, K., Celermajer, D. (2015). Late outcomes in adults with coarctation of the aorta. Heart, 101(15), 1190-1195. [More Information]
• Ayer, J., Charakida, M., Deanfield, J., Celermajer, D. (2015). Lifetime risk: childhood obesity and cardiovascular risk. European Heart Journal, 36(22), 1371-1376. [More Information]
• Cordina, R., Leaney, J., Golzan, S., Grieve, S., Celermajer, D., Graham, S. (2015). Ophthalmological consequences of cyanotic congenital heart disease: vascular parameters and nerve fibre layer. Clinical and Experimental Ophthalmology, 43(2), 115-123. [More Information]
• Fulcher, J., Patel, S., Nicholls, S., Bao, B., Celermajer, D. (2015). Optical coherence tomography for serial in vivo imaging of aortic plaque in the rabbit: a preliminary experience. Open Heart, 2(1), 1-8. [More Information]
• Mirabel, M., Celermajer, D., Beraud, A., Jouven, X., Marijon, E., Hagege, A. (2015). Pocket-sized focused cardiac ultrasound: strengths and limitations. Archives of Cardiovascular Diseases, 108(3), 197-205. [More Information]
• Marijon, E., Bougouin, W., Tafflet, M., Karam, N., Jost, D., Lamhaut, L., Beganton, F., Pelloux, P., Degrange, H., Celermajer, D., et al (2015). Population movement and sudden cardiac arrest location. Circulation, 131(18), 1546-1554. [More Information]
• Amarasena, N., Kapellas, K., Brown, A., Skilton, M., Maple-Brown, L., Bartold, P., O'Dea, K., Celermajer, D., Slade, G., Jamieson, L. (2015). Psychological distress and self-rated oral health among a convenience sample of Indigenous Australians. Journal of Public Health Dentistry, 75(2), 126-133. [More Information]
• O'Meagher, S., Seneviratne, M., Skilton, M., Munoz, P., Robinson, P., Malitz, N., Tanous, D., Celermajer, D., Puranik, R. (2015). Right Ventricular Mass is Associated with Exercise Capacity in Adults with Repaired Tetralogy of Fallot. Pediatric Cardiology, 36(6), 1225-1131. [More Information]
• Arnott, C., Skilton, M., Ruohonen, S., Juonala, M., Viikari, J., Kahönen, M., Lehtimaki, T., Laitinen, T., Celermajer, D., Raitakari, O. (2015). Subtle increases in heart size persist into adulthood in growth restricted babies: the Cardiovascular Risk in Young Finns Study. Open Heart, 2(1), 1-9. [More Information]
• Marijon, E., Bougouin, W., Karam, N., Beganton, F., Lamhaut, L., Perier, M., Benameur, N., Tafflet, M., Beal, G., Hagege, A., Celermajer, D., et al (2015). Survival from sports-related sudden cardiac arrest: In sports facilities versus outside of sports facilities. American Heart Journal, 170(2), 339-345.e1. [More Information]
• Skilton, M., Pahkala, K., Viikari, J., Ronnemaa, T., Simell, O., Jula, A., Niinikoski, H., Celermajer, D., Raitakari, O. (2015). The association of dietary alpha-linolenic Acid with blood pressure and subclinical atherosclerosis in people born small for gestational age: the special turku coronary risk factor intervention project study. The Journal of Pediatrics, 166(5), 1252-1257.e2. [More Information]
• Lau, E., Celermajer, D., Naeije, R. (2015). The emerging role of the contractile and vascular reserves in pulmonary arterial hypertension. European Respiratory Journal, 45(6), 1758-1759. [More Information]
• Forsdick, V., Iyengar, A., Cairns, T., Gentles, T., Weintraub, R., Celermajer, D., d'Udekem, Y. (2015). Unsatisfactory Early and Late Outcomes After Fontan Surgery Delayed to Adolescence and Adulthood. Seminars in Thoracic and Cardiovascular Surgery, 27(2), 168-174. [More Information]
• Cordina, R., Nakhla, S., O'Meagher, S., Leaney, J., Graham, S., Celermajer, D. (2015). Widespread endotheliopathy in adults with cyanotic congenital heart disease. Cardiology in the Young, 25(3), 511-519. [More Information]

2014

• Dunn, L., Simpson, P., Prosser, H., Lecce (Venuto), L., Yuen, S., Buckle, A., Sieveking, D., Vanags, L., Lim, P., Chow, R., Bao, B., Davies, M., Celermajer, D., Bursill, C., Ng, M., et al (2014). A Critical Role for Thioredoxin Interacting Protein in Diabetes-Related Impairment of Angiogenesis. Diabetes, 63(2), 675-687. [More Information]
• Martinez, G., Bailey, B., Celermajer, D., Patel, S. (2014). A safe and easy technique to sample the coronary sinus - Facilitating a closer look at cardiac disease. International Journal of Cardiology, 176(3), 1321-1322. [More Information]
• Ganigara, M., Collins, N., Tanous, D., Celermajer, D., Puranik, R. (2014). Anomalous left anterior descending coronary artery from the pulmonary artery - The role of cardiac MRI. International Journal of Cardiology, 172(1), e172-e174. [More Information]
• Lau, E., Abelson, D., Dwyer, N., Yu, Y., Ng, M., Celermajer, D. (2014). Assessment of ventriculo-arterial interaction in pulmonary arterial hypertension using wave intensity analysis. European Respiratory Journal, 43(6), 1804-1807. [More Information]
• Kapellas, K., Jamieson, L., Do, L., Bartold, P., Wang, H., Maple-Brown, L., Sullivan, D., O'Dea, K., Brown, A., Celermajer, D., Skilton, M., et al (2014). Associations between periodontal disease and cardiovascular surrogate measures among Indigenous Australians. International Journal of Cardiology, 173(2), 190-196. [More Information]
• Chow, V., Yeoh, T., Ng, A., Pasqualon, T., Scott, E., Plater, J., Whitwell, B., Hanzek, D., Chung, T., Thomas, L., Celermajer, D., Kritharides, L. (2014). Asymptomatic left ventricular dysfunction with long-term clozapine treatment for schizophrenia:a multicentre cross-sectional cohort study. Open Heart, 1, 1-10. [More Information]
• Cordina, R., Grieve, S., Barnett, M., Lagopoulos, J., Malitz, N., Celermajer, D. (2014). Brain volumetric, regional cortical thickness and radiographic findings in adults with cyanotic congenital heart disease. NeuroImage: Clinical, 4, 319-325. [More Information]
• Sim, L., Semsarian, C., Celermajer, D., Puranik, R. (2014). Cardiac Amyloidosis:The Role of Magnetic Resonance Imaging. Open Journal of Clinical Diagnostics, 4, 27-30. [More Information]
• Harmer, J., Keech, A., Veillard, A., Skilton, M., Marwick, T., Watts, G., Meredith, I., Celermajer, D. (2014). Cigarette smoking and albuminuria are associated with impaired arterial smooth muscle function in patients with type 2 diabetes mellitus: a FIELD substudy. Diabetes Research and Clinical Practice, 106(2), 328-336. [More Information]
• Szopos, M., Poussineau, N., Maday, Y., Canniffe, C., Celermajer, D., Bonnet, D., Ou, P. (2014). Computational modeling of blood flow in the aorta - insights into eccentric dilatation of the ascending aorta after surgery for coarctation. Journal of Thoracic and Cardiovascular Surgery, 148(4), 1572-1582. [More Information]
• Padang, R., Dennis, M., Semsarian, C., Bannon, P., Tanous, D., Celermajer, D., Puranik, R. (2014). Detection of Serious Complications by MR Imaging in Asymptomatic Young Adults with Repaired Coarctation of the Aorta. Heart, Lung, and Circulation, 23(4), 332-338. [More Information]
• Lau, E., Vanderpool, R., Choudhary, P., Simmons, L., Corte, T., Argiento, P., DAlto, M., Naeije, R., Celermajer, D. (2014). Dobutamine Stress Echocardiography for the Assessment of Pressure-Flow Relationships of the Pulmonary Circulation. Chest, 146(4), 959-966. [More Information]
• Kapellas, K., Maple-Brown, L., Jamieson, L., Do, L., O'Dea, K., Brown, A., Cai, T., Anstey, N., Sullivan, D., Wang, H., Celermajer, D., Skilton, M., et al (2014). Effect of Periodontal Therapy on Arterial Structure and Function Among Aboriginal Australians: A Randomized, Controlled Trial. Hypertension, 64(4), 702-708. [More Information]
• Skilton, M., Siitonen, N., Wurtz, P., Viikari, J., Juonala, M., Seppala, I., Laitinen, T., Lehtimaki, T., Taittonen, L., Kahonen, M., Celermajer, D., et al (2014). High birth weight is associated with obesity and increased carotid wall thickness in young adults: the cardiovascular risk in young Finns study. Arteriosclerosis, Thrombosis, and Vascular Biology, 34(5), 1064-1068. [More Information]
• McGrath, K., Li, X., Whitworth, P., Kasz, R., Tan, J., McLennan, S., Celermajer, D., Barter, P., Rye, K., Heather, A. (2014). High density lipoproteins improve insulin sensitivity in high-fat diet-fed mice by suppressing hepatic inflammation. Journal of Lipid Research, 55(3), 421-430. [More Information]
• Nayyar, D., Muthiah, K., Kumarasinghe, G., Hettiarachchi, R., Celermajer, D., Kotlyar, E., Keogh, A. (2014). Imatinib for the treatment of pulmonary arterial hypertension and pulmonary capillary hemangiomatosis. Pulmonary Circulation, 4(2), 342-345.
• Chow, V., Ng, A., Seccombe, L., Chung, T., Thomas, L., Celermajer, D., Peters, M., Kritharides, L. (2014). Impaired 6-min walk test, heart rate recovery and cardiac function post pulmonary embolism in long-term survivors. Respiratory Medicine, 108(10), 1556-1565. [More Information]
• Bouzeman, A., Marijon, E., De Guillebon, M., Ladouceu, M., Duthoit, G., Amet, D., Martins, R., Otmani, A., Lavergne, T., Bordachar, P., Celermajer, D., et al (2014). Implantable cardiac defibrillator among adults with transposition of the great arteries and atrial switch operation: Case series and review of literature. International Journal of Cardiology, 177(1), 301-306. [More Information]
• Bougouin, W., Marijon, E., Puymirat, E., Defaye, P., Celermajer, D., Le Heuzey, J., Bovéda, S., Kacet, S., Mabo, P., Barnay, C., et al (2014). Incidence of sudden cardiac death after ventricular fibrillation complicating acute myocardial infarction: a 5-year cause-of-death analysis of the FAST-MI 2005 registry. European Heart Journal, 35(2), 116-122. [More Information]
• Martinez, G., Seco, M., Jaijee, S., Adams, M., Cartwright, B., Forrest, P., Celermajer, D., Vallely, M., Wilson, M., Ng, M. (2014). Introduction of an Interdisciplinary Heart Team-based Transcatheter Aortic Valve Implantation Programme: Short and Mid-term Outcomes. Internal Medicine Journal, 44(9), 876-883. [More Information]
• Dennis, M., Laarkson, M., Padang, R., Tanous, D., Robinson, P., Pressley, L., O'Meagher, S., Celermajer, D., Puranik, R. (2014). Long term followup of aortic root size after repair of tetralogy of Fallot. International Journal of Cardiology, 177(1), 136-138. [More Information]
• O'Meagher, S., Munoz, P., Muthurangu, V., Robinson, P., Malitz, N., Tanous, D., Celermajer, D., Puranik, R. (2014). Mechanisms of maintained exercise capacity in adults with repaired tetralogy of Fallot. International Journal of Cardiology, 177(1), 178-181. [More Information]
• Amarasena, N., Kapellas, K., Skilton, M., Maple-Brown, L., Brown, A., Bartold, P., O'Dea, K., Celermajer, D., Slade, G., Jamieson, L. (2014). Oral health behaviours and perceptions reported by Indigenous Australians living in Darwin, Northern Territory. Community Dental Health, 31(1), 57-61. [More Information]
• Kapellas, K., Skilton, M., Maple-Brown, L., Do, L., Bartold, P., O'Dea, K., Brown, A., Celermajer, D., Jamieson, L. (2014). Periodontal disease and dental caries among Indigenous Australians living in the Northern Territory, Australia. Australian Dental Journal, 59(1), 93-99. [More Information]
• O'Meagher, S., Ganigara, M., Tanous, D., Celermajer, D., Puranik, R. (2014). Progress of right ventricular dilatation in adults with repaired tetralogy of Fallot and free pulmonary regurgitation. IJC Heart & Vessels, 3, 28-31. [More Information]
• Lau, E., Celermajer, D. (2014). Protecting our children from environmental tobacco smoke: one of our great healthcare challenges. European Heart Journal, 35(36), 2452-2453. [More Information]
• Lau, E., Bailey, D., Bailey, E., Torzillo, P., Roach, P., Schembri, G., Corte, T., Celermajer, D. (2014). Pulmonary hypertension leads to a loss of gravity dependent redistribution of regional lung perfusion: a SPECT/CT study. Heart, 100(1), 47-53. [More Information]
• d'Udekem, Y., Iyengar, A., Galati, J., Forsdick, V., Weintraub, R., Wheaton, G., Bullock, A., Justo, R., Grigg, L., Sholler, G., Celermajer, D., Winlaw, D., et al (2014). Redefining expectations of long-term survival after the Fontan procedure: twenty-five years of follow-up from the entire population of Australia and New Zealand. Circulation, 130(11), S32-S38. [More Information]
• O'Meagher, S., Ganigara, M., Munoz, P., Tanous, D., Chard, R., Celermajer, D., Puranik, R. (2014). Right Ventricular Outflow Tract Enlargement Prior to Pulmonary Valve Replacement is Associated with Poorer Structural and Functional Outcomes, in Adults with Repaired Tetralogy of Fallot. Heart, Lung, and Circulation, 23(5), 482-488. [More Information]
• Iyengar, A., Winlaw, D., Galati, J., Gentles, T., Weintraub, R., Justo, R., Wheaton, G., Bullock, A., Celermajer, D., d'Udekem, Y. (2014). The Australia and New Zealand Fontan Registry: description and initial results from the first population-based Fontan registry. Internal Medicine Journal, 44(2), 148-155. [More Information]
• Iyengar, A., Winlaw, D., Galati, J., Wheaton, G., Gentles, T., Grigg, L., Justo, R., Radford, D., Weintraub, R., Bullock, A., Celermajer, D., et al (2014). The extracardiac conduit Fontan procedure in Australia and New Zealand: hypoplastic left heart syndrome predicts worse early and late outcomes. European Journal Of Cardio-Thoracic Surgery, 46(3), 465-473. [More Information]
• Chan, K., Simpson, P., Yong, A., Dunn, L., Chawantanpipat, C., Hsu, C., Yu, Y., Keech, A., Celermajer, D., Ng, M. (2014). The Relationship between Endothelial Progenitor Cell Populations and Epicardial and Microvascular Coronary Disease-A Cellular, Angiographic and Physiologic Study. PloS One, 9(4), 1-12. [More Information]
• Ganigara, M., Tanous, D., Celermajer, D., Puranik, R. (2014). The role of cardiac MRI in the diagnosis and management of sinus venosus atrial septal defect. Annals of Pediatric Cardiology, 7(2), 160-162. [More Information]
• Martinez, G., Ng, B., Wilson, M., Pasupati, S., Robinson, D., Cartwright, B., Adams, M., Celermajer, D., Ng, M. (2014). Transcatheter Valve-in-Valve Replacement in Complex Cyanotic Congenital Heart Disease With a Single Ventricle. JACC: Cardiovascular Interventions, 7(10), e133-e133. [More Information]
• Iyengar, A., Winlaw, D., Galati, J., Celermajer, D., Wheaton, G., Gentles, T., Grigg, L., Weintraub, R., Bullock, A., Justo, R., et al (2014). Trends in Fontan surgery and risk factors for early adverse outcomes after Fontan surgery: The Australia and New Zealand Fontan Registry experience. Journal of Thoracic and Cardiovascular Surgery, 148(2), 566-575. [More Information]
• Woo, K., Kwok, T., Celermajer, D. (2014). Vegan Diet, Subnormal Vitamin B-12 Status and Cardiovascular Health. Nutrients, 6(8), 3259-3273. [More Information]
• Skilton, M., Sullivan, T., Ayer, J., Garden, F., Harmer, J., Leeder, S., Toelle, B., Webb, K., Marks, G., Celermajer, D. (2014). Weight gain in infancy is associated with carotid extra-medial thickness in later childhood. Atherosclerosis, 233(2), 370-374. [More Information]

2013

• Lau, E., Morgan, P., Belousova, E., Toelle, B., Ayer, J., Celermajer, D., Marks, G. (2013). Asymmetric dimethylarginine and asthma: results from the Childhood Asthma Prevention Study. European Respiratory Journal, 41(5), 1234-1237. [More Information]
• Low, A., Celermajer, D. (2013). Author reply. Internal Medicine Journal, 43(5), 609-609. [More Information]
• O'Meagher, S., Choudhary, P., Duflou, J., Puranik, R., Celermajer, D. (2013). Causes of death in tetralogy of Fallot in adults - An autopsy study. International Journal of Cardiology, 168(2), 1547-1548. [More Information]
• Marijon, E., Bougouin, W., Celermajer, D., Perier, M., Dumas, F., Benameur, N., Karam, N., Lamhaut, L., Tafflet, M., Mustafic, H., et al (2013). Characteristics and outcomes of sudden cardiac arrest during sports in women. Circulation. Arrhythmia and Electrophysiology, 6(6), 1185-1191. [More Information]
• Levy, M., Bonnet, D., Mauge, L., Celermajer, D., Gaussem, P., Smadja, D. (2013). Circulating endothelial cells in refractory pulmonary hypertension in children: markers of treatment efficacy and clinical worsening. PloS One, 8(6), 1-10. [More Information]
• Levy, M., Celermajer, D., Szezepanski, I., Boudjemline, Y., Bonnet, D. (2013). Do tertiary paediatric hospitals deal with the same spectrum of paediatric pulmonary hypertension as multicentre registries? European Respiratory Journal, 41(1), 236-239. [More Information]
• Simpson, P., Hoyos, C., Celermajer, D., Liu, P., Ng, M. (2013). Effects of continuous positive airway pressure on endothelial function and circulating progenitor cells in obstructive sleep apnoea: A randomised sham-controlled study. International Journal of Cardiology, 168(3), 2042-2048. [More Information]
• Kapellas, K., Do, L., Bartold, M., Skilton, M., Maple-Brown, L., O'Dea, K., Brown, A., Celermajer, D., Slade, G., Jamieson, L. (2013). Effects of full-mouth scaling on the periodontal health of Indigenous Australians: a randomized controlled trial. Journal of Clinical Periodontology, 40(11), 1016-1024. [More Information]
• Beurtheret, S., Mordant, P., Paoletti, X., Marijon, E., Celermajer, D., Leger, P., Pavie, A., Combes, A., Leprince, P. (2013). Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program). European Heart Journal, 34(2), 112-120. [More Information]
• Celermajer, D., Neal, B. (2013). Excessive Sodium Intake and Cardiovascular Disease: A-Salting Our Vessels. Journal of the American College of Cardiology, 61(3), 344-345. [More Information]
• Skilton, M., Mikkila, V., Wurtz, P., Ala-Korpela, M., Sim, K., Soininen, P., Kangas, A., Viikari, J., Juonala, M., Laitinen, T., Celermajer, D., et al (2013). Fetal growth, omega-3 (n-3) fatty acids, and progression of subclinical atherosclerosis: preventing fetal origins of disease? The Cardiovascular Risk in Young Finns Study 1-3. American Journal of Clinical Nutrition, 97(1), 58-65. [More Information]
• Plichart, M., Thomas, F., Empana, J., Bean, K., Perier, M., Celermajer, D., Hanona, O., Danchin, N., Pannier, B., Jouven, X. (2013). Gender-specific trends in heart rate in the general population from 1992-2007: a study of 226,288 French adults. European Journal of Preventive Cardiology, 20(1), 61-72. [More Information]
• Skilton, M., Raitakari, O., Celermajer, D. (2013). High Intake of Dietary Long-Chain {omega}-3 Fatty Acids Is Associated With Lower Blood Pressure in Children Born With Low Birth Weight: NHANES 2003-2008. Hypertension, 61(5), 972-976. [More Information]
• Canniffe, C., Ou, P., Walsh, K., Bonnet, D., Celermajer, D. (2013). Hypertension after repair of aortic coarctation - A systematic review. International Journal of Cardiology, 167(6), 2456-2461. [More Information]
• Hu, Y., Wei, A., Chook, P., Yin, Y., Cheng, W., Wu, M., Celermajer, D., Woo, K. (2013). Impact of non-cardiovascular surgery on reactive hyperaemia and arterial endothelial function. Clinical and Experimental Pharmacology and Physiology, 40(7), 466-472. [More Information]
• Marijon, E., Bougouin, W., Perier, M., Celermajer, D., Jouven, X. (2013). Incidence of sports-related sudden death in France by specific sports and sex. JAMA, 310(6), 642-643. [More Information]
• Marijon, E., Bougouin, W., Celermajer, D., Perier, M., Benameur, N., Lamhaut, L., Karam, N., Dumas, F., Tafflet, M., Prugger, C., et al (2013). Major regional disparities in outcomes after sudden cardiac arrest during sports. European Heart Journal, 34(47), 3632-3640. [More Information]
• Ou, P., Khraiche, D., Celermajer, D., Agnoletti, G., Le Quan Sang, K., Thalabard, J., Quintin, M., Raisky, O., Vouhe, P., Sidi, D., et al (2013). Mechanisms of coronary complications after the arterial switch for transposition of the great arteries. Journal of Thoracic and Cardiovascular Surgery, 145(5), 1263-1269. [More Information]
• Marijon, E., Tafflet, M., Antero-Jacquemin, J., El Helou, N., Berthelot, G., Celermajer, D., Bougouin, W., Combes, N., Hermine, O., Empana, J., et al (2013). Mortality of French participants in the Tour de France (1947-2012). European Heart Journal, 34(40), 3145-3150. [More Information]
• O'Meagher, S., Celermajer, D., Puranik, R. (2013). Preserved stroke volume late after tetralogy repair, despite severe right ventricular dilatation. Heart, 99(24), 1875-1876. [More Information]
• Lau, E., Jaijee, S., Melehan, K., Wong, K., Yee, B., Grunstein, R., Celermajer, D. (2013). Prevalence of patent foramen ovale and its impact on oxygen desaturation in obstructive sleep apnea. International Journal of Cardiology, 165(1), 35-40. [More Information]
• Cordina, R., O'Meagher, S., Karmali, A., Rae, C., Liess, C., Kemp, G., Puranik, R., Singh, N., Celermajer, D. (2013). Resistance training improves cardiac output, exercise capacity and tolerance to positive airway pressure in Fontan physiology. International Journal of Cardiology, 168(2), 780-788. [More Information]
• Jaijee, S., O'Rourke, R., Puranik, R., Slaughter, R., Strugnal, W., Celermajer, D., Kermeen, F. (2013). Right to left ventricular volume ratio: A novel marker of disease severity in chronic thromboembolic pulmonary hypertension. IJC Heart & Vessels, 1, 17-21. [More Information]
• Low, A., Fowler, D., Manghani, M., Young, I., Garsia, R., Torzillo, P., Youssef, P., Celermajer, D. (2013). Screening and Treating Pulmonary Arterial Hypertension in a Tertiary Hospital-based Multidisciplinary Clinic: The First 200 Patients. Internal Medicine Journal, 43(1), 32-37. [More Information]
• Cordina, R., O'Meagher, S., Gould, H., Rae, C., Kemp, G., Pasco, J., Celermajer, D. (2013). Skeletal muscle abnormalities and exercise capacity in adults with a Fontan circulation. Heart, 99(20), 1530-1534. [More Information]
• Ladouceur, M., Kachenoura, N., Lefort, M., Redheuil, A., Bonnet, D., Celermajer, D., Iserin, L., Mousseaux, E. (2013). Structure and function of the ascending aorta in palliated transposition of the great arteries. International Journal of Cardiology, 165(3), 458-462. [More Information]
• Offen, S., Celermajer, D., Semsarian, C., Puranik, R. (2013). The role of diastolic filling in preserving left ventricular stroke volume - An MRI study. International Journal of Cardiology, 168(2), 1596-1598. [More Information]
• Schuuring, M., Bouma, B., Cordina, R., Gatzoulis, M., Budts, W., Mullen, M., Vis, J., Celermajer, D., Mulder, B. (2013). Treatment of segmental pulmonary artery hypertension in adults with congenital heart disease. International Journal of Cardiology, 164(1), 106-110. [More Information]
• Blyton, D., Skilton, M., Edwards, N., Hennessy, A., Celermajer, D., Sullivan, C. (2013). Treatment of sleep disordered breathing reverses low fetal activity levels in preeclampsia. Sleep, 36(1), 15-21. [More Information]
• Simonneau, G., Gatzoulis, M., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Angel Gomez Sanchez, M., Kumar, R., Landzberg, M., Machado, R., et al (2013). Updated Clinical Classification of Pulmonary Hypertension. Journal of the American College of Cardiology, 62(25 Suppl D), D34-D41. [More Information]
• Skilton, M., Marks, G., Ayer, J., Garden, F., Garnett, S., Harmer, J., Leeder, S., Toelle, B., Webb, K., Baur, L., Celermajer, D. (2013). Weight gain in infancy and vascular risk factors in later childhood. Pediatrics, 131(6), e1821-e1828. [More Information]

2012

• Lau, E., Iyer, N., Ilsar, R., Bailey, B., Adams, M., Celermajer, D. (2012). Abnormal Pulmonary Artery Stiffness in Pulmonary Arterial Hypertension: In Vivo Study with Intravascular Ultrasound. PloS One, 7(3), 1-6. [More Information]
• McGrath, K., Li, X., Gaus, K., Williams, P., Celermajer, D., Handelsman, D., Heather, A. (2012). Androgens Rapidly Activate Nuclear Factor-Kappa B via Intracellular Ca2 Signalling in Human Vascular Endothelial Cells. Journal of Steroids & Hormonal Science, S2, 1-6. [More Information]
• Ting, R., Keech, A., Drury, P., Donoghoe, M., Hedley, J., Jenkins, A., Davis, T., Lehto, S., Celermajer, D., Simes, R., Rajamani, K., et al (2012). Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment - The FIELD Study. Diabetes Care, 35(2), 218-225. [More Information]
• Celermajer, D., Chow, C., Marijon, E., Anstey, N., Woo, K. (2012). Cardiovascular Disease in the Developing World: Prevalences, Patterns, and the Potential of Early Disease Detection. Journal of the American College of Cardiology, 60(14), 1207-1216. [More Information]
• Skilton, M., Sullivan, T., Ayer, J., Harmer, J., Toelle, B., Webb, K., Marks, G., Celermajer, D. (2012). Carotid extra-medial thickness in childhood: Early life effects on the arterial adventitia. Atherosclerosis, 222(2), 478-482. [More Information]
• Rose, M., Strange, G., King, I., Arnuop, S., Vidmar, S., O'Donnell, C., Kermeen, F., Grigg, L., Weintraub, R., Celermajer, D. (2012). Congenital heart disease-associated pulmonary arterial hypertension: preliminary results from a novel registry. Internal Medicine Journal, 42(8), 874-879. [More Information]
• Dalton, B., McNeil, K., Keogh, A., Williams, T., Proudman, S., Gabbay, E., Kotlyar, E., Weintraub, R., Kermeen, F., Celermajer, D., et al (2012). Design and delivery of an e-learning curriculum for physicians involved in the management of pulmonary hypertension. International Journal of Clinical Practice, 66(11), 1117-1124. [More Information]
• O'Meagher, S., Munoz, P., Alison, J., Young, I., Tanous, D., Celermajer, D., Puranik, R. (2012). Exercise capacity and stroke volume are preserved late after tetralogy repair, despite severe right ventricular dilatation. Heart, 98(21), 1595-1599. [More Information]
• Talib, J., Pattison, D., Harmer, J., Celermajer, D., Davies, M. (2012). High plasma thiocyanate levels modulate protein damage induced by myeloperoxidase and perturb measurement of 3-chlorotyrosine. Free Radical Biology and Medicine, 53(1), 20-29. [More Information]
• Skilton, M., Ayer, J., Harmer, J., Webb, K., Leeder, S., Marks, G., Celermajer, D. (2012). Impaired Fetal Growth and Arterial Wall Thickening: A Randomized Trial of Omega-3 Supplementation. Pediatrics, 129(3), e698-e703. [More Information]
• Don, G., Joseph, F., Celermajer, D., Corte, T. (2012). Ironic case of hepatic dysfunction following the global withdrawal of sitaxentan. Internal Medicine Journal, 42(12), 1351-1354. [More Information]
• Zahnd, G., Vray, D., Serusclat, A., Alibay, D., Bartold, M., Brown, A., Durand, M., Jamieson, L., Kapellas, K., Maple-Brown, L., Celermajer, D., Skilton, M., et al (2012). Longitudinal displacement of the carotid wall and cardiovascular risk factors: associations with aging, adiposity, blood pressure and periodontal disease independent of cross-sectional distensibility and intima-media thickness. Ultrasound in Medicine and Biology, 38(10), 1705-1715. [More Information]
• Morton, J., Zoungas, S., Li, Q., Patel, A., Chalmers, J., Woodward, M., Celermajer, D., Beulens, J., Stolk, R., Glasziou, P., Ng, M. (2012). Low HDL Cholesterol and the Risk of Diabetic Nephropathy and Retinopathy: Results of the ADVANCE study. Diabetes Care, 35(11), 2201-2206. [More Information]
• Celermajer, D. (2012). Manipulating nature: Might there be a cardiovascular price to pay for the miracle of assisted conception? Circulation, 125(15), 1832-1834. [More Information]
• Thakkar, V., Stevens, W., Prior, D., Moore, O., Byron, J., Liew, D., Patterson, K., Hissaria, P., Roddy, J., Zochling, J., Celermajer, D., Youssef, P., et al (2012). N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study. Arthritis Research and Therapy, 14(3), 1-10. [More Information]
• Marshall, N., Ayer, J., Toelle, B., Phillips, C., Grunstein, R., Celermajer, D., Marks, G. (2012). Parentally Reported Snoring Is Not Enough Information To Justify Treatment. Journal of Paediatrics and Child Health, 48(1), 78-78. [More Information]
• Marijon, E., Mirabel, M., Celermajer, D., Jouven, X. (2012). Rheumatic heart disease. The Lancet, 379(9819), 953-964. [More Information]
• Mirabel, M., Celermajer, D., Ferreira, B., Tafflet, M., Perier, M., Karam, N., Mocumbi, A., Jani, D., Sidi, D., Jouven, X., Marijon, E. (2012). Screening for rheumatic heart disease: evaluation of a simplified echocardiography-based approach. European journal of Echocardiography, 13(12), 1024-1029. [More Information]
• Golzan, S., Leaney, J., Cordina, R., Avolio, A., Celermajer, D., Graham, S. (2012). Spontaneous retinal venous pulsatility in patients with cyanotic congenital heart disease. Heart and Vessels: an international journal, 27(6), 618-623. [More Information]
• Cordina, R., Celermajer, D., McGuire, M. (2012). Systemic venous anatomy in congenital heart disease: implications for electrophysiologic testing and catheter ablation. Journal of Interventional Cardiac Electrophysiology, 33(2), 143-149. [More Information]
• Flammer, A., Anderson, T., Celermajer, D., Creager, M., Deanfield, J., Ganz, P., Hamburg, N., Luscher, T., Shechter, M., Taddei, S., et al (2012). The assessment of endothelial function: from research into clinical practice. Circulation, 126(6), 753-767. [More Information]
• Rangan, A., Flood, V., Denyer, G., Ayer, J., Webb, K., Marks, G., Celermajer, D., Gill, T. (2012). The effect of dairy consumption on blood pressure in mid-childhood: CAPS cohort study. European Journal of Clinical Nutrition, 66(6), 652-657. [More Information]
• Kwok, T., Chook, P., Qiao, M., Tam, L., Poon, Y., Ahuja, A., Woo, J., Celermajer, D., Woo, K. (2012). Vitamin B-12 supplementation improves arterial function in vegetarians with subnormal vitamin B-12 status. Journal of Nutrition, Health and Aging, 16(6), 569-573. [More Information]

2011

• Levy, M., Celermajer, D., Bourges-Petit, E., Del Cerro, M., Bajolle, F., Bonnet, D. (2011). Add-on therapy with subcutaneous treprostinil for refractory pediatric pulmonary hypertension. The Journal of Pediatrics, 158(4), 584-588. [More Information]
• Davis, J., Darcy, C., Yeo, T., Jones, C., McNeil, Y., Stephens, D., Celermajer, D., Anstey, N. (2011). Asymmetric dimethylarginine, endothelial nitric oxide bioavailability and mortality in sepsis. PloS One, 6(2), e17260-1-e17260-6. [More Information]
• Plichart, M., Celermajer, D., Zureik, M., Helmer, C., Jouven, X., Ritchie, K., Tzourio, C., Ducimetière, P., Empana, J. (2011). Carotid intima-media thickness in plaque-free site, carotid plaques and coronary heart disease risk prediction in older adults. The Three-City Study. Atherosclerosis, 219(2), 917-924. [More Information]
• Lau, E., Manes, A., Celermajer, D., Galie, N. (2011). Early detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward. European Heart Journal, 32(20), 2489-2498. [More Information]
• Skilton, M., Viikari, J., Juonala, M., Laitinen, T., Lehtimaki, T., Taittonen, L., Kahonen, M., Celermajer, D., Raitakari, O. (2011). Fetal Growth and Preterm Birth Influence Cardiovascular Risk Factors and Arterial Health in Young Adults: The Cardiovascular Risk in Young Finns Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 31(12), 2975-2981. [More Information]
• Jouven, X., Escolano, S., Celermajer, D., Empana, J., Bingham, A., Hermine, O., Desnos, M., Perier, M., Marijon, E., Ducimetiere, P. (2011). Heart rate and risk of cancer death in healthy men. PloS One, 6(8), e21310 - 1-e21310 - 7. [More Information]
• Morgan, P., Pattison, D., Talib, J., Summers, F., Harmer, J., Celermajer, D., Hawkins, C., Davies, M. (2011). High plasma thiocyanate levels in smokers are a key determinant of thiol oxidation induced by myeloperoxidase. Free Radical Biology and Medicine, 51(9), 1815-1822. [More Information]
• Ng, A., Chung, T., Yong, A., Wong, H., Chow, V., Celermajer, D., Kritharides, L. (2011). Long-Term Cardiovascular and Noncardiovascular Mortality of 1023 Patients With Confirmed Acute Pulmonary Embolism. Circulation: Cardiovascular Quality and Outcomes, 4(1), 122-128. [More Information]
• Ayer, J., Belousova, E., Harmer, J., Toelle, B., Celermajer, D., Marks, G. (2011). Lung Function Is Associated with Arterial Stiffness in Children. PloS One, 6(10), e26303 - 1-e26303 - 4. [More Information]
• Ayer, J., Belousova, E., Harmer, J., David, C., Marks, G., Celermajer, D. (2011). Maternal cigarette smoking is associated with reduced high-density lipoprotein cholesterol in healthy 8-year-old children. European Heart Journal, 32(19), 2446-2453. [More Information]
• Roberts, P., Boudjemline, Y., Cheatham, J., Eicken, A., Ewert, P., McElhinney, D., Hill, S., Berger, F., Khan, D., Schranz, D., Celermajer, D., et al (2011). Percutaneous Tricuspid Valve Replacement in Congenital and Acquired Heart Disease. Journal of the American College of Cardiology, 58(2), 117-122. [More Information]
• Marshall, N., Ayer, J., Toelle, B., Harmer, J., Phillips, C., Grunstein, R., Celermajer, D., Marks, G. (2011). Snoring is not associated with adverse effects on blood pressure, arterial structure or function in 8-year-old children: The Childhood Asthma Prevention Study (CAPS). Journal of Paediatrics and Child Health, 47(8), 518-523. [More Information]
• Marijon, E., Tafflet, M., Celermajer, D., Dumas, F., Perier, M., Mustafic, H., Toussaint, J., Desnos, M., Rieu, M., Benameur, N., et al (2011). Sports-related sudden death in the general population. Circulation, 124(6), 672-681. [More Information]
• Skilton, M., Maple-Brown, L., Kapellas, K., Celermajer, D., Bartold, P., Brown, A., O'Dea, K., Slade, G., Jamieson, L. (2011). The effect of a periodontal intervention on cardiovascular risk markers in Indigenous Australians with periodontal disease: the PerioCardio study. BMC Public Health, 11(1), 729-1-729-8. [More Information]
• Iyer, N., Lau, E., Ilsar, R., Celermajer, D. (2011). Treatment responsiveness in pulmonary arterial hypertension-Preliminary report on serial intra-arterial Doppler flow velocity waveform measurements. International Journal of Cardiology, 153(2), 219-221. [More Information]
• Smadja, D., Mauge, L., Gaussem, P., d'Audigier, C., Israel-Biet, D., Celermajer, D., Bonnet, D., Levy, M. (2011). Treprostinil increases the number and angiogenic potential of endothelial progenitor cells in children with pulmonary hypertension. Angiogenesis, 14(1), 17-27. [More Information]
• Changsirivathanathamrong, D., Wang, Y., Rajbhandari, D., Maghzal, G., Mak, W., Woolfe, C., Duflou, J., Gebski, V., Dos Remedios, C., Celermajer, D., Stocker, R. (2011). Tryptophan metabolism to kynurenine is a potential novel contributor to hypotension in human sepsis. Critical Care Medicine, 39(12), 2678-2683. [More Information]

2010

• Sieveking, D., Lim, P., Chow, R., Dunn, L., Bao, B., McGrath, K., Heather, A., Handelsman, D., Celermajer, D., Ng, M. (2010). A sex-specific role for androgens in angiogenesis. The Journal of Experimental Medicine, 207(2), 345-352. [More Information]
• Davis, J., Yeo, T., Piera, K., Woodberry, T., Celermajer, D., Stephens, D., Anstey, N. (2010). Angiopoietin-2 is increased in sepsis and inversely associated with nitric oxide-dependent microvascular reactivity. Critical Care, 14: R89(3), 1-8. [More Information]
• Patel, S., Di Bartolo, B., Nakhla, S., Heather, A., Mitchell, T., Jessup, W., Celermajer, D., Barter, P., Rye, K. (2010). Anti-inflammatory effects of apolipoprotein A-I in the rabbit. Atherosclerosis, 212(2), 392-397. [More Information]
• Ilsar, R., Levitt, J., Ng, M., Kritharides, L., Celermajer, D. (2010). Bosentan and improved pulmonary endothelial function in pulmonary arterial hypertension. European Respiratory Journal, 36(6), 1483-1485. [More Information]
• Ayer, J., Harmer, J., Marks, G., Avolio, A., Celermajer, D. (2010). Central arterial pulse wave augmentation is greater in girls than boys, independent of height. Journal of Hypertension, 28(2), 306-313. [More Information]
• Cordina, R., Celermajer, D. (2010). Chronic cyanosis and vascular function: implications for patients with cyanotic congenital heart disease. Cardiology in the Young, 20(3), 242-53. [More Information]
• Puranik, R., Celermajer, D., Muthurangu, V., Taylor, A., Puranik, R. (2010). Congenital heart disease and multi-modality imaging. Heart, Lung, and Circulation, 19(3), 133-144. [More Information]
• Ilsar, R., Chawantanpipat, C., Chan, K., Dobbins, T., Waugh, R., Hennessy, A., Celermajer, D., Ng, M. (2010). Doppler-derived Pulmonary Flow Reserve Detects Pulmonary Microvascular Obstruction in High Primates. Heart, Lung, and Circulation, 19(10), 592-594. [More Information]
• Mackie, F., Rosenberg, A., Harmer, J., Kainer, G., Celermajer, D. (2010). HMG CoA reductase inhibition and endothelial function in children with chronic kidney disease (CKD) - a pilot study. Acta Paediatrica: Nurturing the Child, 99(3), 457-459. [More Information]
• Yeo, T., Lampah, D., Tjitra, E., Gitawati, R., Darcy, C., Jones, C., Kenangalem, E., McNeil, Y., Granger, D., Lopansri, B., Celermajer, D., et al (2010). Increased Asymmetric Dimethylarginine in Severe Falciparum Malaria: Association with Impaired Nitric Oxide Bioavailability and Fatal Outcome. PLoS Pathogens, 6(4), e1000868-1-e1000868-8. [More Information]
• Ayer, J., Song, C., Steinbeck, K., Celermajer, D., Freedman, B. (2010). Increased Tissue Factor Activity in Monocytes from Obese Young Adults. Clinical and Experimental Pharmacology and Physiology, 37(11), 1049-1054. [More Information]
• Wang, Y., Liu, H., McKenzie, G., Witting, P., Stasch, J., Hahn, M., Changsirivathanathamrong, D., Wu, B., Ball, H., Thomas, S., Celermajer, D., Hunt, N., Stocker, R., et al (2010). Kynurenine is an endothelium-derived relaxing factor produced during inflammation. Nature Medicine, 16(3), 279-285. [More Information]
• Cordina, R., Celermajer, D. (2010). Late-Onset Pulmonary Arterial Hypertension After a Successful Atrial or Arterial Switch Procedure for Transposition of the Great Arteries. Pediatric Cardiology, 31(2), 238-241. [More Information]
• Ayer, J., Sholler, G., Celermajer, D. (2010). Left atrial size increases with body mass index in children. International Journal of Cardiology, 141(1), 61-67. [More Information]
• Ilsar, R., Chawantanpipat, C., Chan, K., Dobbins, T., Waugh, R., Hennessy, A., Celermajer, D., Ng, M. (2010). Measurement of pulmonary flow reserve and pulmonary index of microcirculatory resistance for detection of pulmonary microvascular obstruction. PloS One, 5(3), e9601 - 1-e9601 - 9. [More Information]
• Lau, E., Yee, B., Grunstein, R., Celermajer, D. (2010). Patent foramen ovale and obstructive sleep apnea: A new association? Sleep Medicine Reviews, 14(6), 391-395. [More Information]
• Roberts, P., Spina, R., Vallely, M., Wilson, M., Bailey, B., Celermajer, D. (2010). Percutaneous tricuspid valve replacement for a stenosed bioprosthesis. Circulation: Cardiovascular Interventions, 3(4), e14-e15. [More Information]
• Ban, C., Twigg, S., Franjic, B., Brooks, B., Celermajer, D., Yue, D., McLennan, S. (2010). Serum MMP-7 is increased in diabetic renal disease and diabetic diastolic dysfunction. Diabetes Research and Clinical Practice, 87(3), 335-341. [More Information]
• Ayer, J., Harmer, J., David, C., Steinbeck, K., Seale, J., Celermajer, D. (2010). Severe Obesity Is Associated With Impaired Arterial Smooth Muscle Function in Young Adults. Obesity, 19(1), 54-60. [More Information]
• Patel, S., Chung, S., White, G., Bao, B., Celermajer, D. (2010). The "atheroprotective" mediators apolipoproteinA-I and Foxp3 are over-abundant in unstable carotid plaques. International Journal of Cardiology, 145(2), 183-187. [More Information]
• Ilsar, R., Bailey, B., Dobbins, T., Celermajer, D. (2010). The Relationship Between Pulmonary Artery and Pulmonary Capillary Wedge Pressure for the Diagnosis of Pulmonary Vascular Disease. Heart, Lung, and Circulation, 19(1), 38-42. [More Information]
• Cordina, R., Celermajer, D. (2010). Therapeutic approaches in adults with congenital heart disease-associated pulmonary arterial hypertension. European Respiratory Review, 19(118), 300-307. [More Information]

2009

• Patel, S., Puranik, R., Nakhla, S., Lundmand, P., Stocker, R., Wang, X., Lambert, G., Rye, K., Barter, P., Nicholls, S., Celermajer, D. (2009). Acute hypertriglyceridaemia in humans increases the triglyceride content and decreases the anti-inflammatory capacity of high density lipoproteins. Atherosclerosis, 204(2), 424-428. [More Information]
• Ayer, J., Harmer, J., Xuan, W., Toelle, B., Webb, K., Almqvist, C., Marks, G., Celermajer, D. (2009). Dietary supplementation with n-3 polyunsaturated fatty acids in early childhood: Effects on blood pressure and arterial structure and function at age 8 y1-3. American Journal of Clinical Nutrition, 90, 438-446. [More Information]
• Ayer, J., Harmer, J., Nakhla, S., Xuan, W., Ng, M., Raitakari, O., Marks, G., Celermajer, D. (2009). HDL-cholesterol, blood pressure, and asymmetric dimethylarginine are significantly associated with arterial wall thickness in children. Arteriosclerosis, Thrombosis, and Vascular Biology, 29(6), 943-949. [More Information]
• Ilsar, R., Chawantanpipat, C., Chan, K., Waugh, R., Hennessy, A., Celermajer, D., Ng, M. (2009). Measurement of pulmonary flow reserve in higher primates. Clinical and Experimental Pharmacology and Physiology, 36(8), 797-802. [More Information]
• Ayer, J., Harmer, J., Steinbeck, K., Celermajer, D. (2009). Postprandial Vascular Reactivity in Obese and Normal Weight Young Adults. Obesity, 18(5), 945-951. [More Information]
• Chow, C., Joshi, R., Celermajer, D., Patel, A., Neal, B. (2009). Recalibration of a Framingham risk equation for a rural population in India. Journal of Epidemiology and Community Health, 63(5), 379-385. [More Information]
• Patel, S., Drew, B., Nakhla, S., Duffy, S., Murphy, A., Barter, P., Rye, K., Chin-Dusting, J., Hoang, A., Sviridov, D., Celermajer, D., et al (2009). Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes. Journal of the American College of Cardiology, 53(11), 962-971. [More Information]
• Celermajer, D. (2009). Wait for weight or waste" the waist the benefits of early intervention in childhood obesity.". Journal of the American College of Cardiology, 54(25), 2407-2408. [More Information]

2008

• Agnoletti, G., Ou, P., Celermajer, D., Boudjemline, Y., Marini, D., Bonnet, D., Aggoun, Y. (2008). Acute angulation of the aortic arch predisposes a patient to ascending aortic dilatation and aortic regurgitation late after the arterial switch operation for transposition of the great arteries. Journal of Thoracic and Cardiovascular Surgery, 135(3), 568-572. [More Information]
• Yeo, T., Lampahc, D., Gitawatie, R., Tjitra, E., Kenangalem, E., Piera, K., Price, R., Duffull, S., Celermajer, D., Anstey, N. (2008). Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria. Proceedings of the National Academy of Sciences of the United States of America, 105(44), 17097-17102. [More Information]
• Ou, P., Celermajer, D., Raisky, O., Jolivet, O., Buyens, F., Herment, A., Sidi, D., Bonnet, D., Mousseaux, E. (2008). Angular (Gothic) aortic arch leads to enhanced systolic wave reflection, central aortic stiffness, and increased left ventricular mass late after aortic coarctation repair: evaluation with magnetic resonance flow mapping. Journal of Thoracic and Cardiovascular Surgery, 135(1), 62-68. [More Information]
• Patel, S., Celermajer, D., Bao, B. (2008). Atherosclerosis - Underlying inflammatory mechanisms and clinical implications. International Journal of Biochemistry and Cell Biology, 40(4), 576-580. [More Information]
• Ayer, J., Almafragy, H., Patel, A., Hellyer, R., Celermajer, D. (2008). Body mass index is an independent determinant of left atrial size. Heart, Lung, and Circulation, 17(1), 19-24. [More Information]
• McGrady, M., Thanyasiri, P., Bailey, B., Celermajer, D., Adams, M. (2008). Determinants of coronary arterial flow-mediated dilatation following percutaneous coronary intervention. Catheterization and Cardiovascular Interventions, 71(3), 327-332. [More Information]
• Chow, C., McQuillan, B., Raju, P., Iyengar, S., Raju, R., Harmer, J., Neal, B., Celermajer, D. (2008). Greater adverse effects of cholesterol and diabetes on carotid intima-media thickness in South Asian Indians: Comparison of risk factor-IMT associations in two population-based surveys. Atherosclerosis, 199(1), 116-122. [More Information]
• Ou, P., Celermajer, D., Jolivet, O., Buyens, F., Herment, A., Sidi, D., Bonnet, D., Mousseaux, E. (2008). Increased central aortic stiffness and left ventricular mass in normotensive young subjects after successful coarctation repair. American Heart Journal, 155(1), 187-193. [More Information]
• Puranik, R., Bao, B., Nobecourt, E., Nicholls, S., Dusting, G., Barter, P., Celermajer, D., Rye, K. (2008). Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo. Atherosclerosis, 196(1), 240-247. [More Information]
• Yeo, T., Lampah, D., Gitawati, R., Tjitra, E., Kenangalem, E., McNeil, Y., Darcy, C., Granger, D., Weinberg, J., et al, Celermajer, D. (2008). Recovery of Endothelial Function in Severe Falciparum Malaria: Relationship with Improvement in Plasma l-Arginine and Blood Lactate Concentrations. The Journal of Infectious Diseases, 198(4), 602-608. [More Information]
• Kilian, J., Thanyasiri, P., Celermajer, D., Adams, M. (2008). Saphenous Vein Grafts Display Poor Endothelium-Dependent and Endothelium-Independent Dilation - Implications for the Pathogenesis of Vein Graft Atherosclerosis. Heart, Lung, and Circulation, 17(2), 96-99. [More Information]
• Chow, C., Naidu, S., Raju, P., Raju, R., Joshi, R., Sullivan, D., Celermajer, D., Neal, B. (2008). Significant lipid, adiposity and metabolic abnormalities amongst 4535 Indians from a developing region of rural Andhra Pradesh. Atherosclerosis, 196, 943-952. [More Information]
• Thomas, G., Chook, P., Yip, T., Kwong, S., Chan, T., Qiao, M., Huang, X., Guo, D., Feng, J., Chan, S., Celermajer, D., et al (2008). Smoking without exception adversely affects vascular structure and function in apparently healthy Chinese: implications in global atherosclerosis prevention. International Journal of Cardiology, 128(2), 172-177. [More Information]
• Sieveking, D., Buckle, A., Celermajer, D., Ng, M. (2008). Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. Journal of the American College of Cardiology, 51(6), 660-668. [More Information]
• Lattimore, J., Wilcox, I., Adams, M., Kilian, J., Celermajer, D. (2008). Treatment of obstructive sleep apnoea leads to enhanced pulmonary vascular nitric oxide release. International Journal of Cardiology, 126, 229-233. [More Information]
• Celermajer, D., Ng, M. (2008). Where there's smoke.. Journal of the American College of Cardiology, 51(18), 1772-4. [More Information]

2007

• Puranik, R., Greaves, K., Hawker, R., Pressley, L., Robinson, P., Celermajer, D. (2007). Abnormal Right Ventricular Tissue Velocities After Repair of Congenital Heart Disease-Implications for Late Outcomes. Heart, Lung, and Circulation, 16(4), 295-299. [More Information]
• Patel, S., Drew, B., Duffy, S., Nahkla, S., Rye, K., Barter, P., Celermajer, D., Kingwell, B. (2007). Abstract 1047: Infusion of Reconstituted High Density Lipoproteins Into Humans Enhances the In Vitro Anti-Inflammatory Capacity of the High Density Lipoprotein Fraction. Circulation, 116, II_209.
• Chandrasegaram, M., Celermajer, D., Wilson, M. (2007). Apical ballooning syndrome complicated by acute severe mitral regurgitation with left ventricular outflow obstruction – Case report. Journal of Cardiothoracic Surgery, 2(14), 1-14. [More Information]
• Chow, C., Cardona-Morrell, M., Raju, P., Iyengar, S., Sukumar, A., Raju, C., Colman, S., Madhav, P., Raju, R., Reddy, K., Celermajer, D., Neal, B. (2007). Cardiovascular disease and risk factors among 345 adults in rural India-the Andhra Pradesh Rural Health Initiative. International Journal of Cardiology, 116(2), 180-185. [More Information]
• Patel, S., Harmer, J., Loughnan, G., Skilton, M., Steinbeck, K., Celermajer, D. (2007). Characteristics of cardiac and vascular structure and function in Prader-Willi syndrome. Clinical Endocrinology, 66(6), 771-777. [More Information]
• Marijon, E., Trinquart, L., Jani, D., Jourdier, H., Garbarz, E., Mocumbi, A., Celermajer, D., Ferreira, B. (2007). Coronary heart disease and associated risk factors in sub-Saharan Africans. Journal of Human Hypertension, 21(5), 411-414. [More Information]
• Ou, P., Celermajer, D., Agnoletti, G., Brunelle, F., Vouhe, P., Sidi, D., Bonnet, D. (2007). Definitive diagnosis of pulmonary artery sling in a critically ill infant with high resolution computed tomography. Circulation, 115, e398-e399. [More Information]
• Brooks, B., Franjic, B., Ban, C., Swaraj, K., Yue, D., Celermajer, D., Twigg, S. (2007). Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes. Diabetes, Obesity and Metabolism, online publication(doi: 10.1111/j.1463-1326.2007.00803.x), 1-8. [More Information]
• Celermajer, D., Marwick, T. (2007). Echocardiographic and right heart catheterization techniques in patients with pulmonary arterial hypertension. International Journal of Cardiology, 125, 294-303. [More Information]
• Levy, M., Maurey, C., Celermajer, D., Vouhe, P., Danel, C., Bonnet, D., Israel-Biet, D. (2007). Impaired apoptosis of pulmonary endothelial cells is associated with intimal proliferation and irreversibility of pulmonary hypertension in congenital heart disease. Journal of the American College of Cardiology, 49(7), 803-810. [More Information]
• Yeo, T., Lampah, D., Gitawati, R., Tjitra, E., Kenangalem, E., McNeil, Y., Darcy, C., Granger, D., Weinberg, J., Lopansri, B., Celermajer, D., et al (2007). Impaired nitric oxide bioavailability and L-arginine-reversible endothelial dysfunction in adults with falciparum malaria. The Journal of Experimental Medicine, 204(11), 2693-2704. [More Information]
• Maple-Brown, L., Piers, L., O'Rourke, M., Celermajer, D., O'Dea, K. (2007). Increased arterial stiffness in remote Indigenous Australians with high risk of cardiovascular disease. Journal of Hypertension, 25(3), 585-591. [More Information]
• Maple-Brown, L., Cunningham, J., Celermajer, D., O'Dea, K. (2007). Increased carotid intima-media thickness in remote and urban Indigenous Australians: impact of diabetes and components of the metabolic syndrome. Clinical Endocrinology, 66(3), 419-425. [More Information]
• Marijon, E., Ou, P., Celermajer, D., Ferreira, B., Mocumbi, A., Jani, D., Paquet, C., Jacob, S., Sidi, D., Jouven, X. (2007). Prevalence of Rheumatic Heart Disease Detected by Echocardiographic Screening. New England Journal of Medicine, 357(5), 470-476. [More Information]
• Celermajer, D. (2007). Protecting children from passive smoking. Circulation, 115, 3143-3144. [More Information]
• Proudman, S., Stevens, W., Sahhar, J., Celermajer, D. (2007). Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment. Internal Medicine Journal, 37(7), 485-494. [More Information]
• Webb, R., Wilson, N., Lennon, D., Marijon, E., Celermajer, D., Jouven, X. (2007). Rheumatic Heart Disease Detected by Echocardiographic Screening. New England Journal of Medicine, 357(20), 2088-2089. [More Information]
• Skilton, M., Sieveking, D., Harmer, J., Franklin, J., Loughnan, G., Nakhla, S., Sullivan, D., Caterson, I., Celermajer, D. (2007). The effects of obesity and non-pharmacological weight loss on vascular and ventricular function and structure. Diabetes, Obesity and Metabolism, 10(10), 874-884. [More Information]
• Brand-Miller, J., Dickinson, S., Barclay, A., Celermajer, D. (2007). The glycemic index and cardiovascular disease risk. Current Atherosclerosis Reports, 9(6), 479-85. [More Information]
• Ou, P., Celermajer, D., Mousseux, E., Giron, A., Aggoun, Y., Szezepanski, I., Sidi, D., Bonnet, D. (2007). Vascular remodelling after "successful" repair of coarctation: impact of aortic arch geometry. Journal of the American College of Cardiology, 49(8), 883-890. [More Information]

2006

• Celermajer, D. (2006). A new era of management in pulmonary hypertension. World Congress of Cardiology.
• Puranik, R., Bao, B., Celermajer, D., Rye, K., Barter, P., Nicholls, S., Nobecourt, E. (2006). A single infusion of lipid free apo A1 can rescue vascular inflammation. Atherosclerosis Supplements, 7, 153.
• Puranik, R., Nobecourt, E., Bao, B., Davies, M., Barter, P., Celermajer, D., Rye, K. (2006). Abstract 1355: The Impact of Glycation on the Anti-inflammatory Properties of High Density Lipoproteins in vivo. Circulation, 114, II-257-II-258.
• Ou, P., Mousseaux, E., Celermajer, D., Pedroni, E., Vouhe, P., Sidi, D., Bonnet, D. (2006). Aortic arch shape deformation after coarctation surgery: effect on blood pressure response. Journal of Thoracic and Cardiovascular Surgery, 132(5), 1105-1111. [More Information]
• Patel, S., Celermajer, D. (2006). Assessment of vascular disease using arterial flow mediated dilatation. Pharmacological Reports, 58, 3-7. [More Information]
• Kotlyar, E., Sy, R., Keogh, A., Kermeen, F., Macdonald, P., Hayward, C., McNeil, K., Celermajer, D. (2006). Bosentan for the treatment of pulmonary arterial hypertension associated with congenital cardiac disease. Cardiology in the Young, 16(3), 268-274. [More Information]
• Celermajer, D., Ayer, J. (2006). Childhood risk factors for adult cardiovascular disease and primary prevention in childhood. Heart, 92(11), 1701-1706. [More Information]
• Nicholls, S., Lundman, P., Harmer, J., Cutri, B., Griffiths, K., Rye, K., Barter, P., Celermajer, D. (2006). Consumption of saturated fat impairs the anti-inflammatory properties of high-density lipoproteins and endothelial function. Journal of the American College of Cardiology, 48(4), 715-720. [More Information]
• Skilton, M., Celermajer, D. (2006). Endothelial dysfunction and arterial abnormalities in childhood obesity. International Journal of Obesity, 30(7), 1041-1049. [More Information]
• Thanyasiri, P., Kathir, K., Celermajer, D., Adams, M. (2006). Endothelial dysfunction and restenosis following percutaneous coronary intervention. International Journal of Cardiology, 119(3), 362-367. [More Information]
• Celermajer, D. (2006). Endothelial function in humans. Jagellonian Medical Research Foundation.
• Chow, C., McQuillan, B., Raju, K., Raju, R., Celermajer, D. (2006). High levels of subclinical atherosclerosis in rural south Asian Indians could be explained by impaired protection by HDL. Annual Scientific Session of the American College of Cardiology (2006), United States: Elsevier Inc.
• Celermajer, D. (2006). How early should we measure endothelial dysfunction? World Congress of Cardiology.
• Lau, A., Chaufour, X., McLachlan, C., Leichtweis, S., Celermajer, D., Sullivan, C., Stocker, R. (2006). Intimal thickening after arterial balloon injury is increased by intermittent repetitive hypoxia, but intermittent repetitive hyperoxia is not protective. Atherosclerosis, 185(2), 254-263. [More Information]
• Skilton, M., Gosby, A., Wu, B., Ho, L., Stocker, R., Caterson, I., Celermajer, D. (2006). Maternal undernutrition reduces aortic wall thickness and elastin content in offspring rats without altering endothelial function. Clinical Science, 111(4), 281-287. [More Information]
• Celermajer, D. (2006). Physiology of the post-coarctation aorta. Image et Function Seminar.
• Thanyasiri, P., Celermajer, D., Adams, M. (2006). Predictors of long-term outcome following percutaneous coronary intervention in patients with type 2 diabetes mellitus. Coronary Artery Disease, 17(2), 131-138. [More Information]
• Tanous, D., Brasen, J., Choy, K., Wu, B., Kathir, K., Lau, A., Celermajer, D., Stocker, R. (2006). Probucol inhibits in-stent thrombosis and neointimal hyperplasia by promoting re-endothelialization. Atherosclerosis, 189(2), 342-349. [More Information]
• Skilton, M., Celermajer, D. (2006). The effects of obesity-related peptides on the vasculature. Current Vascular Pharmacology, 4(1), 79-85. [More Information]
• Woo, K., Yip, T., Kwong, S., Chook, P., Hu, Y., HUang, X., Woo, L., Celermajer, D. (2006). The impact of vitamin B12 and folic acid supplementation on atherosclerosis in rural Chinese: A novel strategy for atherosclerosis prevention in China. World Congress of Cardiology 2006, United Kingdom: Oxford University Press.
• Chow, C., Raju, P., Raju, K., Reddy, K., Cardona-Morrell, M., Celermajer, D., Neal, B. (2006). The prevalence and management of diabetes in rural Indian Adults. (Letter). Diabetes Care, 29(7), 1717-1718. [More Information]
• Ou, P., Celermajer, D., Calcagni, G., Brunelle, F., Bonnet, D., Sidi, D. (2006). Three-Dimensional CT Scanning: A Novel Diagnostic Modality in Congenital Heart Disease. Heart, 93(8), 908-913. [More Information]
• Lattimore, J., Wilcox, I., Skilton, M., Langenfeld, M., Celermajer, D. (2006). Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation. Thorax, 61(6), 491-495. [More Information]

2005

• Kilian, J., Nakhla, S., Sieveking, D., Celermajer, D. (2005). Adenosine prevents neutrophil adhesion to human endothelial cells after hypoxia/reoxygenation. International Journal of Cardiology, 105(3), 322-326. [More Information]
• Celermajer, D. (2005). Adult congenital heart disease. Echo Australia Meeting.
• Sader, M., McGrath, K., Hill, M., Bradstock, K., Jimenez, M., Handelsman, D., Celermajer, D., Heather, A. (2005). Androgen receptor gene expression in leucocytes is hormonally regulated: implications for gender differences in disease pathogenesis. Clinical Endocrinology, 62(1), 56-63. [More Information]
• Skilton, M., Evans, N., Griffiths, K., Harmer, J., Celermajer, D. (2005). Aortic wall thickness in newborns with intrauterine growth restriction. The Lancet, 365(9469), 1484-1486. [More Information]
• Joshua, A., Celermajer, D., Stockler, M. (2005). Beauty is in the eye of the examiner: reaching agreement about physical signs and their value. Internal Medicine Journal, 35(3), 178-187. [More Information]
• Celermajer, D. (2005). Brachial artery FMD with 5-minute distal cuff occlusion--a useful pathophysiological test after all!. Journal of Applied Physiology, 99(4), 1619. [More Information]
• Celermajer, D. (2005). Cardiovascular implications of Childhood Obesity. World Congress of Paediatric Cardiology and Cardiac Surgery.
• Maple-Brown, L., O'Rourke, M., Piers, L., Celermajer, D., O'Dea, K. (2005). Central obesity is associated with reduced peripheral wave reflection in Indigenous Australians irrespective of diabetes status. Journal of Hypertension, 23(7), 1403-1407. [More Information]
• Chow, C., Amos, D., Celermajer, D. (2005). Cerebrovascular events in young adults after surgical repair of tetralogy of Fallot. Cardiology in the Young, 15(2), 130-132. [More Information]
• Sieveking, D., Woo, K., Fung, K., Lundman, P., Nakhla, S., Celermajer, D. (2005). Chinese herbs Danshen and Gegen modulate key early atherogenic events in vitro. International Journal of Cardiology, 105(1), 40-45. [More Information]
• Nicholls, S., Celermajer, D., Rye, K., Barter, P., Griffiths, K., Cutri, B., Harmer, J., Lundman, P. (2005). Consumption of saturated fat impairs endothelial function and the antiinflammatory properties of high-density lipoproteins. Circulation, 112(17), U43.
• Thanyasiri, P., Celermajer, D., Adams, M. (2005). Endothelial dysfunction occurs in peripheral circulation in patients with acute and stable coronary artery disease. American Journal of Physiology - Heart and Circulatory Physiology, 289(2), H513-H517. [More Information]
• Celermajer, D. (2005). Endothelin and pulmonary hypertension. Australian Pulmonary Hypertension Experts Meeting..
• Skilton, M., Lai, N., Griffiths, K., Molyneaux, L., Yue, D., Sullivan, D., Celermajer, D. (2005). Meal-related increases in vascular reactivity are impaired in older and diabetic adults: insights into roles of aging and insulin in vascular flow. American Journal of Physiology - Heart and Circulatory Physiology, 288(3), H1404-H1410. [More Information]
• Lundman, P., Keech, A., Griffiths, K., Pillai, A., Celermajer, D. (2005). New carotid plaque formation is very common in adult patients with Type 2 diabetes mellitus. Diabetic Medicine, 22(3), 355-356. [More Information]
• Skilton, M., Nakhla, S., Sieveking, D., Caterson, I., Celermajer, D. (2005). Pathophysiological levels of the obesity related peptides resistin and ghrelin increase adhesion molecule expression on human vascular endothelial cells. Clinical and Experimental Pharmacology and Physiology, 32(10), 839-844. [More Information]
• Celermajer, D. (2005). Prevention of long-term cardiovascular disease in children. World Congress of Paediatric Cardiology and Cardiac Surgery.
• Celermajer, D. (2005). Primary and a half prevention: can we identify asymptomatic subjects with high vascular risk? (Editorial Comment). Journal of the American College of Cardiology, 45(12), 1994-1996. [More Information]
• Sheil, M., Luxford, C., Davies, M., Peat, J., Nunn, G., Celermajer, D. (2005). Protein oxidation injury occurs during pediatric cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Surgery, 130(4), 1054-1061. [More Information]
• Celermajer, D. (2005). Putting patients first. 2nd Scientific Symposium, Dual ERA.
• Celermajer, D. (2005). Quality of Life in Pulmonary Hypertension. 4th Scientific Symposium on Endothelin-Related Diseases.
• Kilian, J., Nakhla, S., Griffith, K., Harmer, J., Skilton, M., Celermajer, D. (2005). Reperfusion injury in the human forearm is mild and not attenuated by short-term ischaemic preconditioning. Clinical and Experimental Pharmacology and Physiology, 32(01-Feb), 86-90. [More Information]
• Lattimore, J., Wilcox, I., Nakhla, S., Langenfeld, M., Jessup, W., Celermajer, D. (2005). Repetitive hypoxia increases lipid loading in human macrophages-a potentially atherogenic effect. Atherosclerosis, 179(2), 255-259. [More Information]
• Kilian, J., Celermajer, D., Adams, M. (2005). Safety of coronary angioplasty to chronic total occlusions. International Journal of Cardiology, 103(3), 256-258. [More Information]
• Celermajer, D. (2005). Selective endothelin-A antagonism is not superior to dual endothelin antagonism in the treatment of pulmonary artery hypertension. American Thoracic Society annual scientific sessions.
• Chow, C., Mou, D., Patel, A., Celermajer, D. (2005). The role of the 12-lead ECG as a screening test for cardiac source of embolus. Heart, Lung, and Circulation, 14(4), 242-244. [More Information]
• Keech, A., Grieve, S., Patel, A., Griffiths, K., Skilton, M., Watts, G., Marwick, T., Groshens, M., Celermajer, D. (2005). Urinary albumin levels in the normal range determine arterial wall thickness in adults with Type 2 diabetes: a FIELD substudy. Diabetic Medicine, 22(11), 1558-1565. [More Information]
• Kwok, T., Chook, P., Tam, L., Qiao, M., Woo, J., Celermajer, D., Woo, K. (2005). Vascular dysfunction in Chinese vegetarians: an apparent paradox? Journal of the American College of Cardiology, 46(10), 1957-1958. [More Information]

2004

• Kerridge, I., Stewart, G., Raper, M., Celermajer, D., Willcock, S. (2004). "The Future of Medicine" - What is wrong with medicine today? and Where is the future of medicine?.
• Celermajer, D. (2004). Androgens and atherosclerosis. International Society for Heart Research Scientific Sessions.
• Celermajer, D. (2004). Androgens and the heart. Endocrine Society Of Australia.
• Celermajer, D. (2004). Childhood obesity and atherosclerosis – keynote Lecture. South African Heart Association.
• Celermajer, D. (2004). Cholesterol lowering and atherosclerosis. International Clinical Trials Symposium.
• Celermajer, D. (2004). Closing holes in the heart percutaneously – state of the art. SAARC annual scientific sessions.
• Thomas, G., Chook, P., Qiao, M., Huang, X., Leong, H., Celermajer, D., Woo, K. (2004). Deleterious Impact Of "High Normal" Glucose Levels And Other Metabolic Syndrome Components On Arterial Endothelial Function And Intima-Media Thickness In Apparently Healthy Chinese Subjects: The CATHAY Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 24(4), 739-743. [More Information]
• Heather, A., McGrath, K., Sader, M., Nakhla, S., Jessup, W., Handelsman, D., Celermajer, D. (2004). Dihydrotestosterone Promotes Vascular Cell Adhesion Molecule-1 Expression In Male Human Endothelial Cells Via A Nuclear Factor-κB-Dependent Pathway. Endocrinology, 145(4), 1889-1897. [More Information]
• Celermajer, D. (2004). Dual cholesterol inhibition. South African Heart Association.
• Woo, K., Chook, P., Yu, C., Sung, R., Qiao, M., Leung, S., Lam, C., Metreweli, C., Celermajer, D. (2004). Effects Of Diet And Exercise On Obesity-Related Vascular Dysfunction In Children. Circulation, 109(16), 1981-1986. [More Information]
• Celermajer, D. (2004). Fetal origins of atherosclerosis. South African Heart Association.
• Woodman, R., Celermajer, D., Thompson, P., Hung, J. (2004). Folic Acid Does Not Improve Endothelial Function In Healthy Hyperhomocysteinaemic Subjects. Clinical Science, 106(4), 353-358. [More Information]
• Celermajer, D. (2004). Following the sick aorta. Cardiac Society of Australia and New Zealand.
• Ng, M., Celermajer, D. (2004). Glucocorticoid treatment and cardiovascular disease. Heart, 90(Aug.), 829-830. [More Information]
• Celermajer, D. (2004). Interventions for adults congenital heart disease. South African Heart Association.
• Skilton, M., Ho, L., Gosby, A., Caterson, I., Celermajer, D. (2004). Maternal Undernutrition And Early Postnatal Diet Affect Aortic Structure And Composition In Rats. Journal of the American College of Cardiology, 43 Abstracts(5), 517A-517A.
• Celermajer, D., Greaves, K., Puranik, R., O'Leary, J. (2004). Myocardial Tissue Velocities In The Normal Left And Right Ventricles: Relationships And Predictors. Heart, Lung, and Circulation, 13(4), 367-373.
• Woo, K., Chook, P., Yu, C., Sung, R., Leung, S., Qiao, M., Lam, C., Metreweli, C., Celermajer, D. (2004). Overweight In Children Is Associated With Arterial Endothelial Dysfunction And Intima-Media Thickening. International Journal of Obesity, 28(7), 852-857. [More Information]
• Celermajer, D. (2004). The endothelium for cardiologists. Cardiac Society of Australia and New Zealand.
• Sullivan, D., Celermajer, D., Le Couteur, D., Lam, C. (2004). The Vascular Implications Of Postprandial Lipoprotein Metabolism. Clinical Biochemist Reviews, 25(1), 19-30.
• Celermajer, D. (2004). Vascular biology and obesity – Keynote Lecture. 6th Hong Kong East Meets West Symposium.

2003

• Celermajer, D. (2003). ACE-inhibitors and long-term outcomes. Satellite to the American Heart Association.
• Celermajer, D. (2003). Ageing and cardiovascular disease. Life Extension Symposium.
• Ng, M., Quinn, C., McCrohon, J., Nakhla, S., Jessup, W., Handelsman, D., Celermajer, D., Heather, A. (2003). Androgens Up-Regulate Atherosclerosis-Related Genes in Macrophages From Males But Not Females: Molecular Insights Into Gender Differences in Atherosclerosis. Journal of the American College of Cardiology, 42(7), 1306-1313. [More Information]
• Greaves, K., Mou, D., Patel, A., Celermajer, D. (2003). Clinical criteria and the appropriate use of transthoracic echocardiography for the exclusion of infective endocarditis. Heart, 89(3), 273-275.
• Celermajer, D. (2003). Clinical Trials: Evidence and Unanswered Questions Hypertension. Cerebrovascular Diseases, 16(Suppl. 3), 18-24. [More Information]
• Celermajer, D., Deanfield, J. (2003). Congenital heart disease in adolescents and adults. (CHD in Adolescence). In Anderson RH, Tynan M, Rigby M (Eds.), Paediatric Cardiology, (pp. 1893-1925). London: Churchill Livingstone.
• Sheil, M., Cartmill, T., Nunn, G., Sholler, G., Raitakari, O., Celermajer, D. (2003). Contrast echocardiography: potential for the in-vivo study of pediatric myocardial preservation. Annals of Thoracic Surgery, 75(5), 1542-1549. [More Information]
• Ng, M., Nakhla, S., Baoutina, A., Jessup, W., Handelsman, D., Celermajer, D. (2003). Dehydroepiandrosterone, an adrenal androgen, increases human foam cell formation. Journal of the American College of Cardiology, 42(11), 1967-1974. [More Information]
• Celermajer, D., Deanfield, J. (2003). Diseases of the tricuspid valve. In Anderson RH, Tynan M, Rigby M (Eds.), Paediatric Cardiology, (pp. 1111-1133). London: Churchill Livingstone.
• Liu, P., Wishart, S., Celermajer, D., Jimenez, M., Di Pierro, I., Conway, A., Handelsman, D. (2003). Do reproductive hormones modify insulin sensitivity and metabolism in older men? A randomised, placebo-controlled clinical trial of recombinant human chorionic gonadotropin. European Journal of Endocrinology, 148(1), 55-56. [More Information]
• Griffiths, K., Sader, M., Skilton, M., Harmer, J., Celermajer, D. (2003). Effects of Raloxifene on endothelium-dependent dilation, lipoproteins, and markers of vascular function in postmenopausal women with coronary artery disease. Journal of the American College of Cardiology, 42(4), 698-704. [More Information]
• Celermajer, D. (2003). Heart disease in Australia. Royal Society of New South Wales, Melbourne: University of Melbourne.
• Celermajer, D. (2003). Molecular effects of androgens on the vasculature. Cardiology Grand Rounds, Oxford: Oxford University Press.
• Langenfeld, M., Simmons, L., McCrohon, J., Raitakari, O., Lattimore, J., Hennessy, A., Celermajer, D. (2003). Nitric Oxide does not Mediate the Vasodilation of Early Human Pregnancy. Heart, Lung, and Circulation, 12(3), 142-148. [More Information]
• Celermajer, D. (2003). Non-invasive detection of atherosclerosis. Eleventh Annual Spring Desert Cardiovascular Update.
• Lattimore, J., Celermajer, D., Wilcox, I. (2003). Obstructive sleep apnea and cardiovascular disease. Journal of the American College of Cardiology, 41(9), 1429-1437. [More Information]
• Sader, M., Griffiths, K., Skilton, M., Wishart, S., Handelsman, D., Celermajer, D. (2003). Physiological testosterone replacement and arterial endothelial function in men. Clinical Endocrinology, 59(1), 62-67. [More Information]
• Greaves, K., Bye, P., Parker, G., Celermajer, D. (2003). Prevalence of haemoptysis in adults with pulmonary atresia and ventricular septal defect, and the role of mammary artery collateral vessels. Heart, 89(8), 937-938.
• Lau, A., Leichtweis, S., Hume, P., Mashima, R., Hou, J., Chaufour, X., Wilkinson, B., Hunt, N., Celermajer, D., Stocker, R. (2003). Probucol promotes functional reedothelialization in balloon-injured rabbit aortas. Circulation, 107(15), 2031-2036. [More Information]
• Celermajer, D. (2003). Sex and the heart. 24th Panhellenic Cardiological Conference.
• Celermajer, D. (2003). Size of plaque doesn't matter. Eleventh Annual Spring Desert Cardiovascular Update.
• Puranik, R., Celermajer, D. (2003). Smoking and Endothelial Function. Progress In Cardiovascular Diseases, 45(6), 443-458. [More Information]
• Celermajer, D. (2003). Statins, skin, and the search for a test of endothelial function. Journal of the American College of Cardiology, 42(1), 78-80. [More Information]

2002

• Celermajer, D. (2002). Angiotensin II and atherogenesis. Canadian Vascular Biology Working Group.
• Kilian, J., Keech, A., Adams, M., Celermajer, D. (2002). Coronary collateralization: determinants of adequate distal vessel filling after arterial occlusion. Coronary Artery Disease, 13(3), 155-159. [More Information]
• Sader, M., Celermajer, D. (2002). Endothelial function, vascular reactivity and gender differences in the cardiovascular system. Cardiovascular Research, 53, 597-604. [More Information]
• Freedman, B., Brieger, D., Celermajer, D., Chalmers, J., Tofler, G., Campbell, T., Feneley, M., Marwick, T., Muller, D., Tonkin, A. (2002). Global cardiology comes to Australia: 14th World Congress of Cardiology, Sydney, 5-9 May 2002. Medical Journal of Australia, 177(9), 473-475. [More Information]
• Corretti, M., Anderson, T., Benjamin, E., Celermajer, D., Charbonneau, F., Creager, M., Deanfield, J., Drexler, H., Gerhard-Herman, M., Herrington, D., et al (2002). Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International brachial Artery Reactivity Task Force. Journal of the American College of Cardiology, 39(2), 257-265. [More Information]
• Celermajer, D. (2002). International Cardiovascular Professor Program – Pfizer Canada – lecture tour of Vancouver. Lecture tour of Vancouver.
• Woo, K., Chook, P., Chan, L., Cheung, A., Fung, W., Qiao, M., Lolin, Y., Thomas, G., Sanderson, J., Metreweli, C., Celermajer, D. (2002). Long-term improvement in homocysteine levels and arterial endothelial function after 1-year folic acid supplmentation. The American Journal of Medicine, 112(7), 535-539. [More Information]
• Sader, M., Miller, L., Caine, D., McCredie, R., Corr, M., Robertson, M., Watson, J., Celermajer, D. (2002). Neuropsychological and psychiatric outcomes following coronary surgery or angioplasty: a comparative study. Heart, Lung, and Circulation, 11(2), 95-101. [More Information]
• Heather, A., Nakhla, S., McGrath, K., Martell, S., Yue, D., Celermajer, D., Jessup, W. (2002). Nitroglycerin upregulates matrix metalloproteinase expression by human macrophages. Journal of the American College of Cardiology, 39(12), 1943-1950. [More Information]
• Celermajer, D. (2002). Non-invasive detection of presymptomatic atherosclerosis. Hong Kong College of Cardiology Annual Scientific Sessions.
• Wilson, S., Best, P., Edwards, W., Holmes, D., Carlson, P., Celermajer, D., Lermin, A. (2002). Nuclear factor-kappaB immunoreactivity is present in human coronary plaque and enhanced in patients with unstable angina pectoris. Atherosclerosis, 160(1), 147-153. [More Information]
• Dzau, V., Bernstein, K., Celermajer, D., Cohen, J., Dahlof, B., Deanfield, J., Diez, J., Drexler, H., Ferrari, R., van Gilst, W., et al (2002). Pathophysiologic and therapeutic importance of tissue ACE. Cardiovascular Drugs and Therapy, 16(2), 149-160. [More Information]
• Ng, M., Liu, P., Williams, A., Nakhla, S., Ly, L., Handelsman, D., Celermajer, D. (2002). Prospective study of effect of androgens on serum inflammatory markers in men. Arteriosclerosis, Thrombosis, and Vascular Biology, 22(7), 1136-1141. [More Information]
• Celermajer, D. (2002). Size (of plaque) doesn't matter - the new biology of atherosclerosis. South African Cardiac Society.
• Celermajer, D. (2002). Size of plaque and atherosclerosis risk. Hong Kong College of Cardiology Annual General Meeting.
• Celermajer, D., Greaves, K. (2002). Survivors of coarctation repair: fixed but not cured. Heart, 88, 113-114. [More Information]
• Celermajer, D. (2002). Understanding the pathophysiology of the arterial wall: which method should we choose? European Heart Journal, 4(September), F24-F28.
• Celermajer, D. (2002). Unresolved questions in hypertension. European Stroke Association Annual Scientific Sessions.

2001

• Ly, L., Zhuang, T., Celermajer, D., Handelsman, D., Jimenez, M., Conway, A. (2001). A double-blind, placebo-controlled, randomised clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency. The Journal of Clinical Endocrinology and Metabolism, 86, 4078-4088. [More Information]
• Sader, M., Griffiths, K., Handelsman, D., Celermajer, D., McCredie, R. (2001). Androgenic anabolic steroids and arterial structure and function in male body builders. Journal of the American College of Cardiology, 37, 224-230.
• Celermajer, D. (2001). Angiotensin and Vascular Biology. Taiwanese Heart Association Symposium.
• Celermajer, D. (2001). Brachial artery ultrasound and atherosclerosis. Australasian Society for Ultrasound in Medicine.
• Premawardhana, U., Adams, M., Yue, D., Celermajer, D., Birrell, A. (2001). Cardiovascular structure and function in baboons with Type 1 diabetes - a transvenous ultrasound study. Journal of Diabetes and Its Complications, 15, 174-180.
• Langenfeld, M., Nakhla, S., Death, A., Jessup, W., Celermajer, D. (2001). Endothelin-1 and oxidized low density lipoprotein, but neither alone, increase human monocyte adhesion to endothelial cells. Clinical Science, 101, 731-738.
• Heather, A., Jessup, W., Celermajer, D., Langdenfeld, M., Nakhla, S. (2001). Endothelin-1 plus oxidized low-density lipoprotein, but neither alone, increase human monocyte adhesion to endothelial cells. Clinical Science, 101, 731-738.
• Celermajer, D. (2001). Evidence-based medicine: how good is the evidence? Medical Journal of Australia, 174, 293-295.
• Celermajer, D. (2001). Impact of New Diagnostic and Intervention Options on Prognosis in Coronary Disease. International Congress of Life and Health Assurance.
• Seale, J., Celermajer, D., Raitakari, O. (2001). Impaired vascular responses to nitroglycerin in subjects with coronary atherosclerosis. American Journal of Cardiology, 87, 217-219. [More Information]
• Celermajer, D., Jarvisalo, M., Jartti, L., Nanto-Salonen,, K., Irjala, K., Ronnemaa, T., Hartiala, J., Raitakari, O. (2001). Increased aortic intime-media thickness: a marker of preclinical atherosclerosis in high-risk children. Circulation, 104, 2943-2947.
• Sader, M., Griffiths, K., Handelsman, D., Celermajer, D., McCredie, R., Wishart, S. (2001). Oestradiol improves arterial endothelial function in health men receiving testosterone. Clinical Endocrinology, 54, 175-181. [More Information]
• Sader, M., McCredie, R., Griffiths, K., Wishart, S., Handelsman, D., Celermajer, D. (2001). Oestradiol improves arterial endothelial function in healthy men receiving testosterone. Journal of the American College of Cardiology, 54, 175-181.
• Ng, M., Jessup, W., Celermajer, D. (2001). Sex-related differences in the regulation of macrophage cholesterol metabolism. Current Opinion in Lipidology, 12, 506-510.
• Celermajer, D., Woo, J., Woo, K., Leung,, S., Chook, P., Liu,, B., Ip,, R., Ho, S., Chan, S., Feng, J. (2001). The Mediterranean score of dietary habits in Chinese populations in four different geographical areas. European Journal of Clinical Nutrition, 55, 215-220.
• Dzau, V., Bernstein, M., Celermajer, D. (2001). The Relevance of tissue ACE: manifestations in mechanistic and endpoint data. American Journal of Cardiology, 88, 1-20.
• Woo, K., Chook, P., Chan, W., So, W., Cockram, C., Celermajer, D. (2001). Type I diabetes and arterial dysfunction in asymptomatic Chinese adults. Diabetes Care, 24, 173.

2000

• Celermajer, D. (2000). ACE inhibition and atherogenesis. International tissue ACE symposium.
• Premawardhana, U., Celermajer, D. (2000). Advances in echocardiography. Internal Medicine Journal, 30, 360-366.
• McCrohon, J., Death, A., Nakhla, S., Jessup, W., Handelsman, D., Stanley, K., Celermajer, D. (2000). Androgen receptor expression is greater in macrophages from male than from female donors. Circulation, 101, 224-226. [More Information]
• Celermajer, D. (2000). Benefits of Aggressive Lipid Lowering. Indonesia Atherosclerosis Society.
• Raitakari, O., McCredie, R., Letters, J., Witting, P., Griffiths, K., Sullivan, D., Stocker, R., Celermajer, D. (2000). Coenzyme Q improves LDL resistance to ex vivo oxidation but does not enhance endothelial function in hypercholesterolemic young adults. Free Radical Biology and Medicine, 28, 1100-1105.
• McCrohon, J., Woo, K., Celermajer, D. (2000). Comparison of endothelial function in Caucasian and Chinese women before and after the menopause. Maturitas, 35, 31-37.
• Celermajer, D. (2000). Early Detection of Atherosclerosis. South African Heart Association.
• Raitakari, O., Celermajer, D. (2000). Flow-mediated dilatation. British Journal of Clinical Pharmacology, 50, 397-404.
• Rasko, J., Celermajer, D. (2000). Gene therapy for vascular diseases. In RT Dean, D Kelly (Eds.), Atherosclerosis: Gene Expression, Cell Interactions, and Oxidation, (pp. 112-136). Oxford: Oxford University Press.
• Celermajer, D. (2000). Inflammation in coronary disease. WHF Cardiology Year 2000 Course.
• Miller, O., Tang, S., Keech, A., Pigott, N., Beller, E., Celermajer, D. (2000). Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised double-blind study. The Lancet, 356(9240), 1464-1469. [More Information]
• Hornung, T., Celermajer, D., Sholler, G., Miller, O. (2000). Is nitric oxide implicated in pulmonary arteriovenous fistula formation? Pediatric Cardiology.
• Graham, T., Bernardel, G., Mellen, B., Celermajer, D. (2000). Long term outcome in congenitally corrected transposition of the great arteries. Journal of the American College of Cardiology, 36(1), 255-261.
• Celermajer, D. (2000). New techniques for detecting coronary atherosclerosis. European Society of Cardiology.
• Celermajer, D. (2000). Nitric Oxide and Atherosclerosis. Hong Kong College of Cardiology Annual Scientific Sessions.
• Celermajer, D. (2000). Nitric Oxide and the arterial endothelium. Taiwan Cardiac Society.
• Celermajer, D. (2000). Obesity and Vascular Disease. South African Heart Association.
• Raitakari, O., Adams, M., McCredie, R., Griffiths, K., Stocker, R., Celermajer, D. (2000). Oral vitamin C and endothelial function in smokers: acute improvement, but no sustained beneficial effect. Journal of the American College of Cardiology, 35, 1616-1621.
• Raitakari, O., Adams, M., McCredie, R., Griffiths, K., Stocker, R., Celermajer, D. (2000). Oral vitamin C and endothelial function in smokers: short-term improvement, but no sustained beneficial effect. Journal of the American College of Cardiology, 35, 1616-1621.
• Simons, L., Von Konigsmark, M., Simons, J., Celermajer, D. (2000). Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy post-menopausal women. American Journal of Cardiology, 85, 1297-1301.
• Raitakari, O., Lai, N., Griffiths, K., McCredie, R., Sullivan, D., Celermajer, D. (2000). Preserved endothelial function and enhanced peripheral vasodilation in humans after a fatty meal. Journal of the American College of Cardiology, 36, 417-422.
• Lau, A., Witting, P., Chaufour, X., Celermajer, D., Pettersson, K., Stocker, R. (2000). Protective effects of probucol in two animal models of atherosclerosis. Redox Report, 5, 116-118.
• Celermajer, D. (2000). Recent advances in atherosclerosis. Lebanese Heart Association.
• Celermajer, D. (2000). Risk factors for Australian children. Medical Journal of Australia, 173, S11-12.
• Millane, T., Bernard, E., Jaeggi, E., Uren, R., Cartmill, T., Hawker, R., Homan-Giles, R., Celermajer, D. (2000). Role of ischemia and infarction in the late right ventricular dysfunction following atrial repair of transposition of the great arteries. Journal of the American College of Cardiology, 35, 1661-1668.
• Celermajer, D. (2000). Sex Steroids and the Heart. South African Heart Association.
• Raitakari, O., Celermajer, D. (2000). Testing for endothelial dysfunction. Annals of Internal Medicine, 32, 293-304.
• Celermajer, D. (2000). The effects of risk factors and race on endothelial function. International Atherosclerosis Society.
• Celermajer, D. (2000). The Endothelium and Angiotensin. American Heart Association. High Blood Pressure Research, American Heart Association: American Heart Association.
• Woo, K., Chook, P., Leong, H., Huang, X., Celermajer, D. (2000). The impact of heavy passive smoking on arterial endothelial function in modernized Chinese. Journal of the American College of Cardiology, 36, 1228-1232. [More Information]
• Celermajer, D. (2000). The role of antioxidants in atherosclerosis. International Faculty on Endothelial Function.
• Premawardhana, U., Hoskins, M., Celermajer, D. (2000). Transvenous ultrasound in baboons; a novel window to the cardiovascular system. Clinical Science, 99, 141-147.
• Celermajer, D., Vita, J. (2000). Vascular dysfunction and its contribution to atherogenesis. In RT Dean, D Kelly (Eds.), Atherosclerosis: Gene Expression, Cell Interactions, and Oxidation, (pp. 88-111). Oxford: Oxford University Press.